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Abstract
Lactate (La−) has long been at the center of controversy in research, clinical, and athletic settings. Since its discovery in 
1780, La− has often been erroneously viewed as simply a hypoxic waste product with multiple deleterious effects. Not until 
the 1980s, with the introduction of the cell-to-cell lactate shuttle did a paradigm shift in our understanding of the role of 
La− in metabolism begin. The evidence for La− as a major player in the coordination of whole-body metabolism has since 
grown rapidly. La− is a readily combusted fuel that is shuttled throughout the body, and it is a potent signal for 
angiogenesis irrespec- tive of oxygen tension. Despite this, many fundamental discoveries about La− are still working their 
way into mainstream research, clinical care, and practice. The purpose of this review is to synthesize current 
understanding of La− metabolism via an appraisal of its robust experimental history, particularly in exercise physiology. 
That La− production increases dur- ing dysoxia is beyond debate, but this condition is the exception rather than the rule. 
Fluctuations in blood [La−] in health and disease are not typically due to low oxygen tension, a principle first 
demonstrated with exercise and now understood to varying degrees across disciplines. From its role in coordinating 
whole-body metabolism as a fuel to its role as a signaling molecule in tumors, the study of La− metabolism continues to 
expand and holds potential for multiple clinical applications. This review highlights La−’s central role in metabolism and 
amplifies our understanding of past research.
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Lactate (La−) has long been at the center of controversy in research, clinical, and athletic settings. Since its discovery in 1780, 
La− has often been erroneously viewed as simply a hypoxic waste product with multiple deleterious effects. Not until the 
1980s, with the introduction of the cell-to-cell lactate shuttle did a paradigm shift in our understanding of the role of La− in 
metabolism begin. The evidence for La− as a major player in the coordination of whole-body metabolism has since grown 
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Introduction 
Within the physiological pH range of muscle and blood, 
lactic acid (HLa) is more than 99% dissociated into lactate 
anions (La−) and protons (H+). Therefore, it will generally 
be referred to as “La−” in this review. Unless otherwise 
specifi the l(+) enantiomer of La− is implied. Enanti- 
omers are a pair of stereoisomers which are mirror images 
of each other. In the case of La− (Fig. 1), the C2 carbon 
enous sources, the  l(+) form is by far the most predominant and the 
one produced by glycolytic activity 
is asymmetrical (Chen et al. 2015) leading to enantiomers 
that are sometimes designated as l(+)La− and d(−)La−, 
although perhaps more correctly as (S)-La− and (R)- 
La−, respectively (Cahn et al. 1956). While there is some 
d(−)La− in human tissues and blood from both endogenous 
and exogenous sources, the l(+) form is by far the most 
predominant and the one produced by glycolytic activity. 
Serum d(−)La− concentration is between 0.013 and 0.2 mM 
in healthy humans (Hasegawa et al. 2003; Filiz et al. 2010) 
in comparison with  l(+)La− concentration on the order of 
1.0 mM at rest and more than 15.0 mM after short duration 
maximal effort exercise. 
The oft extolled, and persistent beliefs surrounding 
La− can be found in numerous places, including popular fit- 
ness magazines, scientific literature, the athletic and coach- 
ing community, and clinical treatment. All too often, the 
framework of understanding has stemmed from centuries- 
old conclusions which initially found elevated [La−] in both 
tissues and blood when O2 levels were lower than normal. 
Along the way, La− has been accused of roles in muscle 
soreness and fatigue, some of which are debatable or demon- 
strably incorrect. In acute care situations, [La−] remains 
a frequently utilized prognostic tool to stratify trauma 
patients (Parsikia et al. 2014) as well as to identify risk of 
mortality in the critically ill (Nichol et al. 2010), with many 
clinicians viewing La− as a waste product of hypoxia. This 
misinterpre- tation regarding the source and/or cause of 
hyperlactatemia can have profound implications. These 
misconceptions stem from long-standing assertions that 
have pervaded the scientific literature for more than a 
century. The paradigm of “low O2 evokes high La−” led 
to a simplistic converse deduction that “high La− denotes 
low O2”, a position that was formed on the strength of 
research by Nobel laureates, Fletcher and Hopkins (1907), 
Hill et al. (1924), and Meyer- hof (1930b, 1942) in the 
early twentieth century. Because 
La− accumulates during strenuous exercise, the study of 
La− metabolism has historically been closely tied to research 
into exercise energetics and fatigue. The “anaerobic thresh- 
old” concept (Wasserman and McIlroy 1964) reinforced this 
approach as well as the high La−-low O2 paradigm. Today, 
despite numerous studies demonstrating the role of La− as 
a metabolic fuel, and the discovery of many causative fac- 
tors for La− accumulation other than low O2, the lactate-O2
dogma persists in several research enclaves. 
The aim of this paper is to review La− through a his- 
torical lens, thereby gaining context for a broadening set of 
modern investigations and understanding. In many cases, 
the fundamental research that has brought our understanding 
to this point, and expanded that understanding into numer- 
ous disciplines, originated in the experiments of exercise 
physiologists investigating muscle energetics, most promi- 
nently the work of the George Brooks laboratory. This 
review will include: (1) a reevaluation of the recalcitrant 
view that La− is always a product of inadequate tissue or 
cellular O2; (2) highlighting recent work which recognizes 
La− as a viable metabolite for the brain; (3) a summary of 
the elegant linking of substrate utilization and metabolism 
now known as the astrocyte–neuron lactate shuttle that is 
built upon the foundation of the original cell-to-cell lactate 
shuttle composed by Brooks (1985b); (4) an examination of 
additional roles which elevate La− beyond a simple metabo- 
lite to include signaling functions as a “Lactormone”; and 
(5) assessment of a resurgent interest in the role of La− in 
cancer, in tumorigenesis, and in tumor metabolism. 
In contrast to the dogma that has plagued La− as a dead- 
end, fatigue-causing waste product, we will provide evidence 
of La− as an energy intermediate that can be formed in tis- 
sues undergoing accelerated glycolysis and subsequently dis- 
tributed throughout the body to be taken up as a combustible 
substrate by oxidizing tissues, or as a precursor for glucone- 
ogenesis (e.g., in liver) or glycogenesis (e.g., in liver or rest- 
ing, glycolytic skeletal muscle). Our current understanding 
is that La− is a ubiquitous metabolic intermediate operating 
simultaneously as both the terminal product of glycolytic 
metabolism and the intermediary to complete oxidation of 
carbohydrates by oxidative phosphorylation. A consistent, 
key finding that we hope to impart from these diverse studies 
is the centrality of La− as a metabolic intermediate within 
and between cells. A particularly unique contribution of this 
review is the inclusion of key historical developments and 
misinterpretations in the study of La− metabolism as well 
as a critical appraisal of current, cutting-edge investigations 
in this area. 
Early history of lactate 
In 1780, a German-speaking Swedish apothecary and 
chemist, Carl Wilhelm Scheele (Fig. 2) discovered HLa/ 
Fig. 2 Carl Wilhelm Scheele (1742–1786), discoverer of lactic acid 
and oxygen. Retrieved from (Lundgren 2014). Encyclopedia Britan- 
nica, https://www.britannica.com/biography/Carl-Wilhelm-Scheele. 
Access data August 04, 2017 
La− in sour milk (Benninga 1990). The new acid was named 
‘‘Mjölksyra,’’ meaning ‘‘acid of milk’’ (Benninga 1990). 
Scheele also discovered chlorine, manganese, arsenic acid, 
barium, molybdenum, tungsten, and fl ine along with 
numerous other compounds (West 2014). However, Scheele 
will likely be best remembered as the fi t “modern” dis- 
coverer of oxygen (O2), which he fi t called “vitriol air” 
(West 2014), and later “fi e air” (Scheele and Bergman 
1777; Scheele et al. 1780; Severinghaus 2016). He actually 
discovered O2 as early as 1772, more than a year before 
Joseph Priestley. Unfortunately, his experiments were not 
published until 1777, probably because of procrastination 
by Scheele as well as his friend and advocate, Torbern Berg- 
man, who wrote an introduction to the book (Williams and 
Moyer 1982). There is also a more intriguing subtext to the 
story. In his Traité élementaire de chimie (Lavoisier 1789), 
Lavoisier falsely claimed that O2 was discovered at almost 
the same time “by Mr. Priestley, Mr. Scheele, and myself” 
(Severinghaus 2016). This was a lie, not only because Joseph 
Priestley had communicated his discovery to Lavoisier in 
1774 in person, but also because Scheele had sent Lavoisier 
a letter in the same year describing his 1771 discovery of 
O2 (Grimaux 1890; Severinghaus 2016). This letter from 
Scheele to Lavoisier was kept hidden by Lavoisier and then 
by Lavoisier’s wife’s brother’s descendants for 219 years 
(Severinghaus 2016)! Amazingly, Scheele made his land- 
mark discoveries over a short lifetime, dying at the age of 43 
(West 2014). Severinghaus (2006) speculates that he died as 
a result of tasting his discoveries, including one which was 
sold widely as Scheele’s green cake frosting. The green color 
was due to arsenic, one of Scheele’s discoveries. 
Despite the fact that von Muralt (1950) called the inter- 
vening years between the discovery of La− in 1780 and the 
muscle studies of Fletcher and Hopkins in 1907 (Fletcher 
and Hopkins 1907), “the prelactic acid era,” there were 
some notable La−-related discoveries during this period 
(Brooks and Gladden 2003). Certainly, the fi most 
relevant to exercise physiology was the result by Berzelius 
in 1807 (Berzelius 1848; Needham 1971) that La− concen- 
tration ([La−]) was elevated in “the muscles of hunted stags” 
(Gladden 2008a). Quoting Berzelius (Berzelius 1848), “As 
early as 1807, I analyzed the meat of freshly slaughtered 
animals, and found a free acid in the liquids drawn from it.” 
Apparently, Berzelius also convinced himself that the [La−] 
in a muscle was proportional to the amount of exercise that 
the muscle had performed (Needham 1971). Berzelius and 
others believed that the La− found in muscle was the same 
as that found in sour milk by Scheele in 1780 (Brin 1965). 
However, in 1848, Engelhardt (1848), and later Wislice- 
nus (1873) reported diff ent properties for muscle versus 
milk La− (Brin 1965). Of course, we now know that animal 
tissues produce almost exclusively l(+)lactate, whereas 
microorganisms can produce d(-)lactate or sometimes a 
combination of d(−) and l(+); this can then lead to racemic 
mixtures in, for example, fermented milk (Lockwood et al. 
1965; Caplice and Fitzgerald 1999). 
As detailed by Kompanje et al. (2007), the presence of 
La− in human blood under pathological conditions after 
death was first noted in 1843 and again in 1851 by Scherer 
(1843, 1851). Mosler and Körner (1862; Kompanje et al. 
2007) note that blood from a living patient with leukemia 
was reported positive for La− by Folwarczny in 1858; 5 
years later, similar data were reported for blood from living 
patients with a number of different medical conditions (Fol- 
warczny 1863; Kompanje et al. 2007). Failing to acknowl- 
edge prior research, Gaglio (1866) detected La− in arterial 
blood freshly drawn from dogs and rabbits. In addition, 
neglecting previous work, Berlinerblau (1887) confi med 
the report of Gaglio in mammalian and human venous blood 
(Kompanje et al. 2007). 
The nineteenth century saw progress in understanding 
the metabolic sources of La− in animals. In 1845, Hermann 
von Helmholtz (1845) reported findings that were consistent 
with La− formation at the expense of glycogen (von Muralt 
1950). In 1847, German chemist, von Liebig (1847), founder 
of the world’s fi t school of chemistry, noted the inevita- 
ble presence of La− in muscle tissue from dead organisms 
(Kompanje et al. 2007). Interestingly, Claude Bernard (Ber- 
nard 1855), the discoverer of glycogen in 1859 (Bernard 
1877; Needham 1971), found release of La− from muscles 
excised from calf fetuses and placed in water at 15–20 °C 
and discussed its possible origin (Needham 1971). Shortly 
thereafter, as described by Fletcher and Hopkins (1907), 
Kompanje et al. (2007), and Needham (1971), du Bois- 
Reymond (in several 1859 publications) noted that activity 
caused muscles to become acidic and actually related this 
finding to the increased [La−] reported by Berzelius. Soon 
after (1864), Heidenhain (von Muralt 1950) reported that the 
amount of La− increased with the amount of work done. In 
the next year, as reported by Fletcher and Hopkins (1907), 
Ranke concluded that resting muscle is alkaline but becomes 
acid after excision. Based on his experiments in 1877 and 
1879, Nasse ultimately concluded that La− is derived from 
glycogen (Nasse 1877, 1879; Needham 1971). 
What appears above as a relatively linear, logical pro- 
gression in the study of La− in skeletal muscle is created by 
selective hindsight viewed through the lens of our current 
understanding. Quoting from the classic study of Fletcher 
and Hopkins (1907), just as Needham (Needham 1971) did: 
“there is hardly any important fact concerning the lactic acid 
formation in muscle which, advanced by one observer, has 
not been contradicted by some other.” As support for this 
assessment, Fletcher and Hopkins (1907) cite numerous 
studies reporting that La− was not formed in response to 
either muscle contraction or rigor, and did not accompany 
muscle fatigue. The paper by Fletcher and Hopkins (1907) 
is a landmark classic that will be discussed in the next sec- 
tion on the relationship between La− and hypoxia. Fletcher 
was mentor to A. V. Hill and in 1929, Hopkins was awarded 
the Nobel Prize for “his discovery of growth-stimulating 
vitamins” (Levinovitz and Ringertz 2001). 
The “high La− denotes low O2” paradigm 
Research on disparate cell types established the funda- 
mental concept that fermentation was markedly enhanced 
in the absence of O2. In 1861, Louis Pasteur observed that 
the growth of yeast per gram of sugar consumed was much 
greater under aerobic than anaerobic conditions (Pasteur 
1861; Racker 1974; Barnett 2003). Subsequently, most 
investigators focused on the measurement of the prod- 
ucts of fermentation (alcohol for yeast and La− for skel- 
etal muscle) under O2 versus no-O2 conditions (Racker 
1974). In yeast, the decrease in sugar consumption upon 
the introduction of O2 was accompanied by a decrease in 
fermentation and, therefore, alcohol production. In skel- 
etal muscle, this same phenomenon was later recognized 
as a decrease in glycogen breakdown and a decrease in 
La− formation under aerobic as compared to anaerobic 
conditions (Meyerhof 1930b; Barnett 2003). Although 
Pasteur’s initial discovery occurred in 1861, it was not 
until 1926 that Warburg gave this phenomenon its name, 
the “Pasteur Eff (Warburg 1926; Krebs 1972). The 
intermixing of metabolic research in diff ent cell types 
in the 1920s is illustrated by the fact that Meyerhof and 
Warburg, to mention two giants in the field, both exam- 
ined this Pasteur Eff in yeast, muscle, and other tissues 
(Barnett and Entian 2005). As quoted by Barnett (2003), 
von Euler and colleagues wrote in 1925, “…for some time 
we have been busy with developing the analogy between 
fermentative catabolism in yeast and anaerobic catabolism 
of carbohydrates in muscle” (von Euler et al. 1925). 
The early twentieth century view of hypoxia as the nec- 
essary cause of La− accumulation was promoted and rein- 
forced by several notable contributions. Much of the uncer- 
tainty surrounding La− formation in muscle at the end of 
the nineteenth century was due to methodological problems 
mainly associated with muscle glycogenolysis occurring 
during the muscle sampling and preparation process, prior to 
experimental study. In the aforementioned landmark study, 
Fletcher and Hopkins (1907) developed a method which pre- 
vented significant La− formation in resting muscles before 
the extraction and analysis of the La−. Subsequently, they 
were able to show that: (1) freshly excised resting muscle 
contains a low [La−]; (2) [La−] increases in excised, resting, 
anaerobic muscles; (3) La− accumulates and [La−] increases 
to high levels during stimulation of muscles to fatigue; and 
(4) most importantly in the present context, when fatigued 
muscles are placed in O2-rich environments, La− disappears 
(Brooks and Gladden 2003). As noted above, Nobel Prize 
winner Otto Meyerhof also observed La− accumulation in 
the absence of O2 and its removal upon the return of O2
(Meyerhof 1930a; Krebs 1972). Therefore, it was likely 
that in the context of the Pasteur Eff  in skeletal mus- cle, 
Hill et al. (1924) postulated that La− increased during 
muscular exercise because of a lack of O2 to remove the 
requisite La−  produced by the contracting muscles. This 
view of hypoxia as a cause of La− accumulation was likely 
reinforced by the earlier studies of Araki and also Zillessen 
[cited by (Kompanje et al. 2007)] who had shown that inter- 
ruption of the O2 supply to the muscles of mammals and 
birds promoted an increase in [La−]. 
To be fair, we should note that researchers at that time 
thought that La− formation was of a necessity an anaerobic 
process. Specifically, it was believed that O2 was required to 
combust some of the La− that was produced during muscle 
activity back to some form of carbohydrate. If O2 was not 
available for this combustion, then [La−] would rise. The 
state-of-the-art view of La− metabolism in humans in the 
late 1920s is exemplifi by Jervell’s experiments (Jervell 
1928). He (Jervell 1928) reported numerous experiments 
in which he investigated the concentration of “lactic acid” 
in blood and urine under both physiologic and pathologic 
conditions. Two quotes serve to illustrate the prevailing idea 
that a lack of O2 was the reason for elevated [La−]: 
“During my clinical work, I was naturally induced to 
supplement the experimental investigations by exami- 
nation of the lactic acid’s behavior in various patholog- 
ical conditions. It was then deemed necessary to limit 
these examinations to those conditions, where owing 
to impeded intake of oxygen, we might expect to find 
hyperlactacidaemia.” And “If the oxygen supply…is 
for one or other reason too small, we may expect to 
fi an increase in the quantity of lactic acid in the 
muscles.” 
From the idea that La− production and accumulation was 
due to inadequate O2 supply, it was only a simple, intuitive 
deduction to reach the converse conclusion that increased 
La− production and concentration were the results of, and 
indicators of, hypoxia/dysoxia. 
“Anaerobic” threshold 
Some 40 years later, the idea that inadequate O2 causes 
La− accumulation was the centerpiece of the “anaerobic 
threshold” concept as proposed by Wasserman and McIlroy 
(1964; Wasserman et al. 1973). Although overshadowed by 
Wasserman’s efforts, similar ideas were advanced indepen- 
dently by Hollman, Kinderman, Keul, and others (Kinder- 
mann et al. 1979; Stegmann et al. 1981; Hollmann 1985). In 
a letter of February 21, 2000 to G. A. Brooks, Wasserman 
described his motivations for investigating the “anaerobic 
threshold,” and specifically, non-invasive assessment tech- 
niques for pulmonary medicine (Brooks and Gladden 2003). 
In 1959, Wasserman was a postdoctoral fellow under Julius 
H. Comroe in the University of California, San Francisco 
(UCSF) Cardiology Research Institute. Recognizing the 
“epidemic” in cardiovascular disease, in November of 1960 
Comroe challenged Wasserman to develop procedures for 
early detection of heart disease. Wasserman’s response was 
that evaluation “would be best done during exercise when 
the heart was being stressed…. The first sign of heart fail- 
ure would be refl in the failure of the circulation to 
deliver adequate O2 to the metabolizing tissues (exercising 
muscles). Since the muscle O2 requirement would be mark- 
edly increased by exercise, the failure of the heart to trans- 
port O2 adequately would result in lactic acidosis (Pasteur 
Effect).” (Wasserman letter of 2/21/2000 to Brooks). Aware 
of the earlier reports of Harrison and Pilcher (1930a, b) who 
showed increased CO2 production and reduced O2 uptake 
in heart-failure patients, Wasserman thought “it possible to 
investigate how to detect the V̇ O2 at which lactic acidosis 
developed during exercise, using non-invasive gas exchange 
techniques.” His experience at UCSF led to an appointment 
at Stanford, where Wasserman co-authored a paper with 
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Malcolm B. McIlroy (Wasserman and McIlroy 1964) in 
which “anaerobic threshold” was determined as the V̇ O2 at 
which the respiratory exchange ratio (R) increased abruptly 
during a progressive incremental exercise test. It is inform- 
ative to note that Wasserman discussed his research with 
D.B. Dill and credits Dill with inspiring the term “anaerobic 
threshold.” Wasserman showed Dill his data and the method 
of gas exchange he was using to “detect the work rate at 
which O2 transport was inadequate to prevent an exercise 
lactic acidosis.” Wasserman further states, “As close[ly] as I 
can remember, his [Dill’s] comment was that I was detecting 
the threshold of anaerobic metabolism during exercise by 
measuring exercise gas exchange. Thus, he put into words 
succinctly what I was trying to measure” (Wasserman let- 
ter of 2/21/2000 to Brooks), (Brooks and Gladden 2003). 
A fascinating aspect of Wasserman’s personal account of 
the “anaerobic threshold” concept is its connection to the 
1920s concept of the Pasteur Effect and to the person of D. 
B. Dill who directed the Harvard Fatigue Laboratory from 
1927 to 1947. In 1973, Wasserman et al. (1973) refined the 
concept in their classic paper, defining “anaerobic thresh- 
old” as the “level of work or O2 consumption just below 
that at which metabolic acidosis and the associated changes 
in gas exchange occur.” This non-invasive measure was in 
turn asserted to correspond to the work rate or V̇ O2 above 
which lactate systematically increased in response to an 
increase in work rate. This 1973 paper (Wasserman et al. 
1973) generated great interest which continues to the present 
day with over 2,200 citations according to Google Scholar 
as of August 2, 2017. 
For the subsequent span of over three decades, Wasser- 
man and colleagues vigorously pursued the development of 
non-invasive technologies to identify the presence of lactic 
acidosis in graded clinical exercise protocols. Numerous gas 
exchange measures have been used over the years, and a 
full discussion is beyond the scope of the current review. 
In brief, the so-called V-slope method (Beaver et al. 1986) 
has become the preferred method for determining what is 
currently most appropriately referred to as the gas exchange 
threshold (GET). For the V-slope method of threshold detec- 
tion, carbon dioxide output (V̇ CO2) is plotted against V̇ O2 
and a computerized regression analysis detects the break- 
point in the relationship (Fig. 3). The coincidence of the 
GET with the lactate threshold (see below) as determined 
directly from the pattern of blood [La−] has been heavily 
debated (Caiozzo et al. 1982; Davis et al. 1983; Green et al. 
1983; Simon et al. 1983; Yeh et al. 1983; Gladden et al. 
1985; Plato et al. 2008) and is also beyond the scope of the 
present review. 
While the Wasserman lab emphasized the non-invasive 
measurement of the “anaerobic threshold”, many other 
researchers focused on a direct assessment of the blood 
La− response to exercise of varying intensities. As presaged 
Fig. 3 V-slope method for determining the gas exchange threshold, 
redrawn with permission from (Beaver et al. 1986). Carbon dioxide 
output (V̇ CO2) is plotted against simultaneously  determined  oxy- gen 
uptake (V̇ O2) in a  progressive  incremental  exercise  test.  The gas 
exchange threshold is detected by a mathematical algorithm that 
determines the intersection of the two straight lines that provide the 
best fit to the overall data set 
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Fig. 4 Idealized blood [La−] response to progressive incremental 
exercise plotted against oxygen uptake (V̇ O2). Also illustrated are 
three single point measures often used to describe the response: the 
visually determined lactate threshold (LT) (Gladden et al. 1985), LT 
as determined by the Dmax method (LTD) (Cheng et al. 1992), and the 
onset of blood La− accumulation (OBLA = 4 mM) (Heck et al. 1985). 
Reprinted with permission from Gladden (2004a) Lactate metabolism 
during exercise. In Principles of Exercise Biochemistry, 3rd edn, ed. 
Poortmans JR, pp. 152–196. Karger, Basel 
by Owles (1930), during progressive, incremental exercise, 
blood [La−] rises gradually at first and then more rapidly as 
the exercise becomes more intense; this idealized response is 
shown in Fig. 4. A primary issue in the study of data of this 
type has been the identification and interpretation of a single 
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value that best represents this curvilinear blood La− profile. 
As examples, Fig. 4 illustrates three of these methods; the 
lactate threshold (LT), the onset of blood La− accumulation 
(OBLA), and Dmax (Wasserman et al. 1973, 1986; Gladden 
et al. 1985; Heck et al. 1985; Cheng et al. 1992; Bishop 
et al. 1998; Jones and Doust 1998; Nicholson and Sleiv- 
ert 2001; Gladden 2004a; Faude et al. 2009). While these 
methods often do not provide the same quantitative value, 
they generally correlate well with each other, and each is 
highly correlated with endurance performance (Bishop et al. 
1998; Jones and Doust 1998; Nicholson and Sleivert 2001). 
Depending on the particular protocol, the pattern of increase 
in blood [La−] can differ from the idealized response shown 
in Fig. 4. As one example, some researchers report a second 
“breakpoint” in the response (e.g., Skinner and McLellan 
1980). Nevertheless, we contend that the various indicators 
are correlated with each other. 
Biopsies from exercising muscles have shown that mus- 
cle [La−] shows similar patterns to those of blood [La−] 
although the exercising muscle [La−] is generally higher 
than that in blood (Green et al. 1983; Gollnick et al. 1986). 
The blood [La−] response to progressive exercise has in turn 
been related to the blood [La−] levels that are measured in 
more prolonged, constant work rate exercise (Wasserman 
et al. 1967; Pringle and Jones 2002), and are, therefore, 
more closely related to endurance performance ability. Fig- 
ure 5 provides a schematized view of this response. Exer- 
cise intensities which are below the LT typically result in a 
transient elevation of blood [La−] which then declines to a 
lower level, sometimes returning to near the resting [La−]. 
During exercise that elicits metabolic rates between LT (V̇ 
O2LT) and 50% of the difference between V̇ O2LT and V̇ O2peak
{50%Δ = V̇ O2LT + 0.5 (V̇ O2peak − V̇ O2LT)}, many subjects 
reach their maximal lactate steady state (MLSS) (Pringle 
and Jones 2002). MLSS is defined as the highest intensity of 
exercise that can be performed while maintaining a constant, 
but elevated blood [La−] (Beneke and von Duvillard 1996; 
Jones and Doust 1998). Operationally, exercise intensities 
that are greater than the MLSS are identified as metabolic 
rates that result in an increase of more than 1.0 mM in blood 
[La−] during the last 20 min of a 30-min constant work rate 
trial (Beneke and von Duvillard 1996; Jones and Doust 
1998; Pringle and Jones 2002; Gladden 2004a). At work 
rates exceeding the MLSS, both blood [La−] and V̇ O2 drift 
upward until exhaustion occurs. Although the drifts in [La−] 
and V̇ O2 share a similar time course, there is apparently no 
cause-and-effect relationship between the two (Poole et al. 
1994; Gaesser and Poole 1996; Billat et al. 1998). Despite 
the idealized representation in Fig. 5, there is a surprising 
range of blood [La−]s at the MLSS; e.g., 1.5–6.3 mM (Ped- 
ersen et al. 2001). Several indices of physiological thresh- 
olds of exercise intensity occur at the same metabolic rate 
(i.e., V̇ O2) (Keir et al. 2015) or at least are highly correlated 
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Fig. 5 Blood [La−] response to constant work rate exercise at dif- 
ferent intensities. Idealized data based on the reports of Wasserman 
et al. (1967, 1986) and Pringle and Jones (Pringle and Jones 2002) 
are plotted. Blood [La−] responses for work rates below (< MLSS), 
at (= MLSS) and greater than (> MLSS) the maximal lactate steady 
state intensity are shown. Although the usual blood [La−] at  the MLSS 
is approximately 4 mM, this concentration can vary widely among 
individuals (Pedersen et al. 2001). Reprinted with permission from 
Gladden (2004a) Lactate metabolism during exercise. In Prin- ciples 
of Exercise Biochemistry, 3rd edn, ed. Poortmans JR, pp. 152– 
196. Karger, Basel 
(Pringle and Jones 2002); these include critical power, mus- 
cle deoxyhemoglobin breakpoint, and the MLSS. 
Essentially, Wasserman’s anaerobic threshold hypothesis 
implies that the accumulation of La− during muscular exer- 
cise is due to “dysoxia.” Dysoxia as defined by Connett et al. 
(1990) is a sufficiently low level of O2, such that cytochrome 
turnover is limited, and therefore, there is O2-limited oxida- 
tive phosphorylation. As will be detailed in the following 
sections, the preponderance of evidence argues against this 
paradigm, and therefore, whether determined either inva- 
sively via blood [La−] or non-invasively via gas exchange, 
threshold measures should not be termed “anaerobic.” 
Prime evidence for causative factors other than low 
O2 
Today, it is well established that any increase in [La−] 
typically represents something other than an O2 limitation; 
hypoxia-driven La− accumulation is very much the excep- 
tion rather than the rule. As reviewed by Barnard and Hol- 
loszy (2003), results of experiments conducted in 1885 by 
Rubner and Frey should have raised questions about the rela- 
tionship between La− and O2. These investigators perfused 
mammalian muscles with oxygenated blood and observed 
La− release despite the presence of apparently suffi 
O2. Zuntz (1911; Barnard and Holloszy 2003) actually dis- 
cussed these results in 1911, but remained convinced that 
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hypoxic conditions were a prerequisite for La− accumula- 
tion. Intriguingly, Zuntz proposed that some parts of the 
muscles might have been hypoxic because of arterial blood 
clots or narrowing of blood vessels (Zuntz 1911; Barnard 
and Holloszy 2003); perhaps, an early suggestion of “occult 
hypoperfusion” (see below). In a different arena of research 
in the 1920s, the Cori’s (Cori and Cori 1925) and Warburg 
(Warburg et al. 1927) carried out whole animal experiments, 
demonstrating that limbs bearing tumors had high venous 
[La−] despite presumed normoxic conditions. Glucose-avid, 
La−-producing tumors in normoxic conditions were eventu- 
ally labeled as demonstrating a “Warburg eff ” Recent 
interest in tumor metabolism has proven this to be much 
less straightforward than originally described, as it is now 
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proposed that there may be thousands of cancer genotypes 
(Lundberg 2011) yielding a much smaller but still large 
number of cancer phenotypes, and even among the same 
tumor type, La− uptake or output can vary markedly with 
arterial [La−] (Sauer and Dauchy 1985). However, the Cori’s 
and Warburg (Cori and Cori 1925; Warburg et al. 1927) 
provided early experimental animal evidence that La− pro- 
duction and/or accumulation need not be linked obligatorily 
with hypoxia. The Warburg eff was thought to be char- 
acteristic of some tumors, but not reflective of any normal 
physiology (after all, why would there be increased [La−] 
in normoxia?). As a result of this thinking and perhaps the 
isolation of research into silos, the Cori’s and Warburg’s 
intriguing results were never transposed to the field of exer- 
cise metabolism as a challenge to the prevailing dogma of 
the next approximately 60 years. 
It was not until the 1960s that evidence against the notion 
of low O2 as a prerequisite for La− production and accumula- 
tion began to gain traction. During the same era, when Was- 
serman and colleagues were detailing the “anaerobic thresh- 
old,” other investigations were underway that argued against 
an O2 limitation as the causative factor for La− accumu- 
lation. Utilizing a canine gastrocnemius-superficial digital 
flexor complex (GS) in situ, Stainsby and Welch (Stainsby 
and Welch 1966) aimed to investigate La− production in 
response to various steady contraction rates. Surprisingly, 
they found that net La− output by the contracting GS was 
always transient (Fig. 6). During contractions over periods 
of 40–60 min, net La− output peaked and declined within 
15–20 min, even becoming net La− uptake as the contrac- 
tions continued at a constant stimulation rate. If hypoxia 
were the cause of La− production in contracting muscle, 
then why would net La− output decline to near zero or 
even revert to net La− uptake with continued contractions 
at an unchanged metabolic rate and unchanged O2 delivery 
(Brooks and Gladden 2003)? 
To answer this question, Stainsby forged a collaboration 
with Frans Jöbsis who, with Britton Chance, had invented 
the surface fluorescence method for NAD+/NADH detection 
Fig. 6 Net La− output and uptake across an isolated, blood-perfused, 
contracting skeletal muscle (canine gastrocnemius-superficial digital 
flexor complex; N = 5) at rest and during contractions at 5 twitches 
per sec over a period of 1 hour, followed by 30 min of recovery. Net 
La− output is positive on the y-axis and net La− uptake is negative. 
Note that net La− output during contractions peaks at approximately 
10 min and then declines and often becomes net uptake as the con- 
tractions continue. See text for additional details. Redrawn with per- 
mission from Welch and Stainsby (1967) 
(Brooks and Gladden 2003). Using this NAD+/NADH fluo- 
rescence technique in the isolated canine GS, Jöbsis and 
Stainsby (1968) found that the redox pair was highly reduced 
at rest but became highly oxidized quickly after the onset of 
contractions, suggesting an adequate O2 supply for oxidative 
phosphorylation. If O2 is inadequate, oxidative phosphoryla- 
tion will be restrained and the electron transport chain will 
“back up” thus causing a reduction in the NAD+/NADH 
redox couple. Therefore, the net La− output at contraction 
onset that Stainsby and Welch had previously observed, 
could not be explained by hypoxic/dysoxic stimulation of 
anaerobic glycolysis (Jöbsis and Stainsby 1968). Certainly, 
these experiments are subject to criticism on several grounds 
(Gladden 1996) including the fact that the surface fluorom- 
etry technique is unable to distinguish between NADH and 
NADPH (Akerboom et al. 1979; Unkefer et al. 1983; Katz 
and Sahlin 1988) or to distinguish between redox changes 
within the mitochondria versus the cytosol (Kushmerick 
1983; Paddle 1985; Katz and Sahlin 1988), the former being 
much more reduced (Williamson et al. 1967; Jones and Sies 
2015). Nevertheless, the totality of the Stainsby studies 
promoted a re-consideration of the relationship between 
La− production and hypoxia. 
The next major blows against dysoxia as the cause of 
La− production by contracting/exercising skeletal muscle 
involved measures of intracellular partial pressure of O2
(PiO2). Granted that a sufficiently low O2 level resulting in 
dysoxia will limit mitochondrial oxidative phosphorylation, 
a prime question results: how much O2 is enough to prevent 
inhibition and allow normal mitochondrial function? Studies 
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in isolated mitochondria and whole cells contend that PiO2
in the range of 0.5 to 2.0 Torr is sufficient for maximal mito- 
chondrial oxidative phosphorylation (Chance and Williams 
1956; Wilson et al. 1988; Connett et al. 1990; Gnaiger et al. 
1995; Gnaiger and Kuznetsov 2002). Direct exploration into 
potential O2-limited muscle La− production was initially 
provided by measuring myoglobin saturation (and thereby 
PiO2) via cryomicrospectroscopy combined with measures 
of [La−] from approximately the same cell populations in 
isolated, perfused dog gracilis muscle (Connett et al. 1984). 
At rest and during submaximal twitch contractions, approxi- 
mating 10 and 70% of peak twitch V̇ O2 in this muscle, myo- 
globin saturation did not decrease in the fi t seconds of 
stimulation, remained greater than 5 mmHg at all sampling 
locations during transition from rest to contraction, and 
remained greater than 2 mmHg in the steady state (Connett 
et al. 1984). Over the same time course, muscle [La−] rose 
from 1.2 mmol kg− 1 at rest to 2.0 mmol kg− 1 at the 10% V̇ 
O2peak contraction rate and to 5.7 mmol kg− 1 at the 70% V̇ 
O2peak contraction rate. While technical limitations of this 
cryomicrospectroscopy method were more fully revealed in 
later work (Voter and Gayeski 1995), the conclusions still 
stand. From their results, Connett et al. (1983, 1984, 1986) 
concluded that fully aerobic La− accumulation occurs in red 
muscle and that the accumulation results from causes other 
than O2-limitation of mitochondrial ATP production. 
More recently, proton magnetic resonance spectroscopy 
(1H-MRS) was used to determine myoglobin saturation dur- 
ing single-leg, maximal eff t, quadriceps contractions in 
humans, concluding similarly that increased La− efflux from 
the exercising muscle did not result from inadequate muscle 
PiO2 (Richardson et al. 1998). Even while breathing hypoxic 
gas (12% O2), local O2 tension was never low enough to 
unequivocally limit oxidative phosphorylation (Richardson 
et al. 1998). Furthermore, there was no correlation between 
net blood La− efflux from the exercising quadriceps and PiO2
across a range of metabolic rates from 50 to 100% of V̇ O2max. 
The PiO2 data from this study are discussed in more detail 
below. 
This evidence strongly suggests that frank dysoxia is not 
one of the causes of a rise in muscle and blood La− lev- 
els at submaximal exercise intensities. The major, legiti- 
mate underlying mechanisms for the increase in [La−] with 
increasing exercise intensity have been discussed in detail 
elsewhere (Gladden 1996, 2004a, b) and include acceler- 
ating glycolysis, failure of La− removal to keep pace with 
La− production [e.g., (Brooks 1985a)], and recruitment of 
fast twitch muscle fibers (Ivy et al. 1980; Armstrong 1988). 
Accelerated glycolysis will always result in an increase in 
La− production because of the near-equilibrium nature of the 
lactate dehydrogenase (LDH) reaction, and because LDH 
has a much higher activity than the key regulatory enzymes 
of the glycolytic and oxidative pathways; thus, La− is always 
the end-product of glycolysis (Kane 2014; Rogatzki et al. 
2015; Schurr 2017). 
Is there any role for hypoxia in the rising [La−] 
with increasing exercise intensity? 
Despite the fact that La− accumulation has been observed 
consistently in the absence of dysoxia, an important ques- 
tion remains: does O2 play any role whatsoever in increasing 
[La−] with increasing metabolic intensity? The short answer 
is that La− production is not associated with a clearly defined 
dysoxic condition in skeletal muscle, but in an apparent 
inconsistency, La− accumulation during exercise is signifi- 
cantly affected by perturbations in O2 delivery during heavy 
exercise. A fuller answer to the question follows. 
Even though exercising skeletal muscle PiO2 does not 
decrease to the level of absolute inhibition of mitochondrial 
oxidative phosphorylation function, it is nevertheless true 
that skeletal muscle PiO2 declines with increasing exercise 
intensity. PiO2 is a diffi measurement to make during 
exercise. The most convincing data rely on derived val- 
ues from myoglobin desaturation as determined via proton 
nuclear magnetic resonance spectroscopy (1H NMRS) along 
with accurate values of myoglobin P50. Using best evidence 
from this technique, how does PiO2 change as a function 
of exercise intensity? In studies of plantar flexion exercise 
in Jue’s laboratory (Molé et al. 1999; Chung et al. 2005), 
PiO2 was reported to decline progressively and linearly with 
increasing work rate, down to ≈ 3.1 Torr. However, in the 
majority of studies, most directed by Richardson and col- 
leagues employing single-leg knee-extensor exercise, which 
limits activity to the quadriceps femoris muscle group, the 
nadir is reached at approximately 50–60% of V̇ O2max and 
remains there with further increases in exercise intensity 
(Richardson et al. 1998, 1999, 2001, 2002). Similar data 
have been reported by Vanderthommen et al. (2003). Fig- 
ure 7 (Clanton et al. 2013) combines data from Molé et al. 
(1999) with those of Richardson et al. (2001) including 
the most reliable data available for resting PiO2 in which 
Richardson, in collaboration with Carlier (Richardson et al. 
2006), employed a 4.0 T magnet to measure myoglobin 
desaturation. Notably, considering the different muscle 
groups studied, and the diff ent protocols employed, the 
results are much more congruent than expected across labo- 
ratories and techniques. Overall, these data demonstrate that 
the largest reductions in PiO2 occur relatively early in incre- 
mentally increasing exercise, but reach a relative plateau in 
moderate-to-heavy exercise. Since we know that significant 
muscle La− production occurs at exercise levels above a 
metabolic threshold of approximately 50–60% of V̇ O2max, it 
appears that La− production is not associated with a clearly 
defined dysoxic condition in skeletal muscle, at least during 
single muscle group exercise. 
Fig. 7 Intracellular PO2 (PiO2) versus metabolic rate using  com- bined 
data of Molé et al. [(1999); solid squares] and Richardson et al. 
[(2001); solid circles]. Data from Richardson et al. (2006) working 
in Carlier’s lab were used as the resting value for both sets of data, 
so the square is overlying a circle. In addition, note that the reported 
PiO2  value at 100% of V̇ O2max  was the same for both data sets, so 
again, the square is overlying the circle. Reprinted with permission 
from Clanton et al. (2013) 
Fig. 8 Hypothetical pattern of metabolic dependence (La− produc- 
tion) on intracellular PO2 (PiO2) during the transition from one 
exercise work rate to another. With increase in work rate (arrow 1), 
[ADP]·[Pi]/[ATP] increases. However, intracellular PO2 will likely 
also decrease with increased work rate (arrow 2). As a result, O2 
uptake would be transiently insufficient to supply ATP at the required 
rate, leading to a further increase in  [ADP]·[Pi]/[ATP]  (arrow  3, from 
open circle to solid square) for adequate stimulation of oxida- tive 
phosphorylation. The connection to La− metabolism is that the 
increases  in  [ADP]·[Pi]/[ATP]  simultaneously  accelerate  glyco- − 
Yet, paradoxically, La−  accumulation during heavy lysis and, therefore, La production (see text for additional details). 
whole-body exercise is signifi    y aff     by perturba- tions 
in O2 delivery. Wasserman reviewed this evidence 
(Wasserman 1984; Wasserman and Koike 1992), much of 
which dates well back before the turn of the century. When 
subjects inspire gas with a lower PO2, blood La− levels are 
elevated during exercise [e.g., (Lundin and Ström 1947)]. 
For the same heavy work rate, blood [La−] is higher in isov- 
olemic anemia as compared to the normal, control state [e.g., 
(Woodson et al. 1978)]. Adding carbon monoxide (CO) to 
the inspired gas sufficient to bind 15–20% of the O2 bind- 
ing sites on hemoglobin also increases blood [La−] during 
exercise (Vogel and Gleser 1972). A reduction in circulat- 
ing blood volume in normal subjects results in an increase 
in exercise [La−] [e.g., (Fortney et al. 1981)]. Patients with 
a low cardiac output due to disease (Huckabee and Judson 
1958), as well as normal subjects subjected to beta-block- 
ade via propranolol (Twentyman et al. 1981) also display 
an exaggerated blood [La−] response to exercise. Admin- 
istration of an inotropic drug to cardiac patients with low 
exercise tolerance reduces the blood [La−] increase dur- 
ing exercise (Siskind et al. 1981). Finally, it has been well 
demonstrated that breathing hyperoxic gases will cause a 
reduction in blood [La−] during exercise [e.g., (Hogan et al. 
1983)]. 
Therefore, even in the absence of apparent dysoxia, 
glycolytic metabolism and La− production are at least 
somewhat O2 dependent. How could this be? Certainly, 
one possibility is that blood catecholamine concentrations 
are higher during hypoxic conditions (Mazzeo et al. 1991; 
Reprinted with permission from Clanton et al. (2013) 
Richardson et al. 1998; Mazzeo and Reeves 2003). How- 
ever, an additional hypothesis relies on cellular changes 
in the [ADP]·[Pi]/[ATP] ratio that occur in high metabolic 
states as a mechanism for acute responses to hypoxia. This 
idea is illustrated in the hypothetical example shown in 
Fig. 8 (Clanton et al. 2013). Suppose an individual is exer- 
cising at approximately 55% of V̇ O2max (solid circle) and 
then transitions to a higher work rate, just above 70% V̇ 
O2max. Abundant evidence demonstrates that at the higher 
work rate, cytosolic [ADP] and [Pi] will be elevated, while 
[ATP] will perhaps be slightly decreased, leading to an 
increase in [ADP]·[Pi]/[ATP]. As such, the V̇ O2–PiO2 
curve will be shifted upward, as indicated by arrow 1 and 
extensively reported by Wilson and colleagues (Wilson 
et al. 1979, 1988; Wilson 1994). However, based on the 
results of Molé et al. (1999) and Richardson et al. (2001), 
there will also be a decrease in PiO2 (arrow 2). This small 
reduction in PiO2 would then result in movement down 
the V̇ O2–PiO2 curve, thus reducing V̇ O2 (open circle). 
This reduction in V̇ O2 below the required level would 
result in additional accumulation of ADP and Pi, elevat- 
ing [ADP]·[Pi]/[ATP] further, shifting the mitochondria to 
yet a higher V̇ O2–PiO2 curve (arrow 3). Ultimately, shifts 
to higher [ADP]·[Pi]/[ATP] ratios as energy consump- 
tion increases could lead to an equilibrium state, where 
PiO2 remains relatively constant, but V̇ O2 can continue 
to increase. This is consistent with observations of the 
relatively constant PiO2 in moderate-to-severe exercise, 
as shown in Fig. 7. 
What connects the preceding discussion to increased 
glycolysis and La− production in non-dysoxic muscle? The 
link is that any increase in [ADP]·[Pi]/[ATP] required to 
elevate V̇ O2 is a very powerful stimulus for glycolytic activ- 
ity, independent of any changes in PiO2. Furthermore, as one 
moves to higher [ADP]·[Pi]/[ATP] levels, the O2 depend- 
ence of the V̇ O2–PiO2 curve becomes greater, as reviewed 
by Gnaiger et al. (2001), and Scandurra and Gnaiger (2010). 
With changes in available PiO2, the system can sustain a 
constant V̇ O2, but there will be resultant elevations in 
[ADP]·[Pi]/[ATP] which, in turn, stimulate glycolysis. The 
system is O2 sensitive, because as available O2 decreases or 
increases, it can increase or decrease the necessary eleva- 
tions in [ADP]·[Pi]/[ATP] and thus also increase or decrease 
the glycolytic rate. There is experimental evidence to sup- 
port this hypothesis as a mechanism for O2 dependence of 
La− production [e.g., (Hogan et al. 1992a, b; Haseler et al. 
1998; Richardson et al. 1998)]. These data support the 
hypothesis that it is not a limited oxidative phosphorylation 
engendered by a low dysoxic PiO2 that drives La− produc- 
tion, but rather the elevations in [ADP]·[Pi]/[ATP] required 
to sustain metabolic rate and to drive mitochondrial respira- 
tion at the extant low PiO2. 
One might ask if this requisite increase in La− production 
and blood [La−] represents an additional energy expendi- 
ture and, therefore, a decrease in efficiency. Quantification 
of energy expenditure due to La− accumulation is fraught 
with diffi (Gladden 2004a). The [La−] varies among 
muscles due to differing degrees of recruitment for a given 
activity and blood [La−] varies depending on the tissue being 
drained. Even if an average [La−] could be determined, the 
dilution space is undefi and non-uniform. Neverthe- less, 
using a series of assumptions, calculations based on the 
results of Bransford and Howley (1977) to account for 
energy provided by anaerobic glycolysis (i.e., net La− accu- 
mulation) lead to an estimated decrease in effi of    about 
2% at approximately 90% of V̇ O2max. Note, however, that 
this calculation does not mean that the use of ATP syn- 
thesized via anaerobic pathways is inherently less efficient 
than the use of aerobically synthesized ATP (Gladden and 
Welch 1978). Careful measures of delta efficiency (Gaesser 
and Brooks 1975) at submaximal work rates (almost entirely 
aerobic) versus very heavy work rates (signifi   anaero- bic 
contribution) suggest that delta effi decreases 
with increasing work rate, regardless of the contribution of 
anaerobic energy pathways (Gladden and Welch 1978). 
It is very important to note here that if an individual is in 
a steady state in which the [La−] is unchanging, there is no 
additional energy being provided above that determined via 
O2 consumption (Brooks 2012). Even though La− is formed 
continuously from glycolysis, it is largely combusted as a 
fuel, thereby being accounted for by the measurement of O2
consumption (Brooks 2012). 
Lactate and fatigue 
Exercise and skeletal muscle fatigue are complex processes 
with numerous potential causes ranging from central nervous 
system function to the activity of myosin at the individual 
cross-bridge level (Gladden 2016). However, during intense 
muscle contractions or exercise, [La−] increases dramatically 
and contributes significantly to a decrease in pH within the 
active muscles and in the case of whole-body exercise, the 
blood. During intense dynamic exercise, intracellular water 
[La−] can reach 30 mM and intracellular pH can decline to 
the range of 6.2–6.5 (Sahlin et al. 1976; Debold et al. 2016). 
For a discussion of La−’s role in acidosis, see a following 
section in this review. A complete discussion of the potential 
role of La− and pH in fatigue would require a full review of 
its own, so we offer only an abbreviated discussion here. 
Classic support for lactic acidosis as a cause of fatigue 
in human exercise was provided by imperfect studies that 
employed prior exercise to elevate [La−] and decrease pH 
[e.g., (Klausen et al. 1972; Karlsson et al. 1975; Bangsbo 
and Juel 2006)]. As a detailed example, Yates, Gladden 
and Cresanta (Yates et al. 1983) had participants perform 
a 1-min maximal eff t cycle ergometer task prior to iso- 
metrically maintaining 40% of maximum voluntary contrac- 
tion (MVC) force to exhaustion with the elbow flexors. The 
prior exercise elevated blood [La−] to 11 mM and decreased 
arterialized blood pH to 7.20. As a result, isometric endur- 
ance was reduced by 25%, although there was no effect of 
the prior exercise on MVC, peak rate of force increase, peak 
rate of force decrease, one-half contraction time, or one-half 
relaxation time. 
Certainly, the lactate anion (La−) could be a fatigue agent. 
For example, Hogan et al. (1995) reported that infusion of 
isolated canine gastrocnemius muscles with blood [La−] at 
12–15 mM caused a 15% decrease in twitch tension, even 
though muscle pH was not altered from control conditions. 
Supportive findings have been published for isolated mus- 
cles in vitro (Spangenburg et al. 1998), skinned muscle 
fi (Andrews et al. 1996), and sarcoplasmic reticulum 
vesicles [e.g., (Favero et al. 1995; Spangenburg et al. 1998)]. 
In addition, Samaja et al. (1999) found that La− apparently 
depressed developed pressure irreversibly in Langendorff 
perfused rat hearts; overall, the eff of elevated [La−] were 
more deleterious than the effects of high [H+]. In con- trast, 
other investigators have reported effects of 5% or less on 
muscle contractility in skinned mammalian muscle fibers 
[e.g., (Posterino et al. 2001)]. In fact, Allen et al. (2008) have 
summarized evidence against La− and dismissed its potential 
role as a fatigue agent, largely on the basis of studies with 
skinned muscle fibers. Our view is that while the impact of 
high [La−] per se in the fatigue phenomenon has been heav- 
ily challenged by investigations in vitro, it remains feasible 
that the La− anion has a small but potentially significant 
deleterious effect in intact systems such as perfused skeletal 
muscle and heart and intact humans. We also note that while 
a 5% fatigue eff does not argue for a central role in the 
fatigue process, it is also not negligible. 
What about acidosis and fatigue? In 2006 (Bangsbo and 
Juel 2006; Lamb and Stephenson 2006) and again in 2016 
(Fitts 2016; Westerblad 2016), the role of decreased pH in 
fatigue was directly debated. Historically, lactic acid was 
viewed as one of the major causes of muscle and exercise 
fatigue (Fitts 1994). As early as 1929, Hill and Kupalov 
(Hill and Kupalov 1929) proposed lactic acid accumula- 
tion as the cause of fatigue during twitch contractions of 
frog sartorii at temperatures in the range of 14–20 °C. More 
recently, it has been noted that the negative effects of low pH 
on peak isometric force in studies of isolated muscle fibers 
are much smaller at higher temperatures such as 30 °C [see 
(Fitts 2016)]. However, research from the Fitts laboratory 
(Knuth et al. 2006; Nelson et al. 2014; Fitts 2016) has found 
that low pH (down to 6.2) at 30 °C depressed velocity and 
power of skinned muscle fibers by 30–35%! These deleteri- 
ous effects were even greater in the presence of inorganic 
phosphate concentration ([Pi]) elevated to the level seen dur- 
ing intense exercise. The fatiguing effect of combined low 
pH and high [Pi] may be further increased in the presence of 
suboptimal [Ca2+] such as occurs during fatigue (Fitts 2016). 
Debold et al. (2016) have recently reviewed the fatiguing 
effects of elevated [H+], elevated [Pi], and decreased Ca2+
sensitivity determined from both isolated muscle fiber stud- 
ies and investigations at the level of the contractile protein, 
myosin, and the muscle regulatory proteins, troponin, and 
tropomyosin. 
Despite the evidence outlined in the previous paragraph 
and the prior dogma that acidosis is a major cause of fatigue, 
there is a plethora of data opposing this position (Lamb and 
Stephenson 2006; Westerblad 2016). Westerblad (2016) 
noted that there are several studies (Sahlin and Ren 1989; 
Westerblad and Allen 1992; Degroot et al. 1993) which 
failed to find a temporal correlation between acidosis and 
a decrease in muscle function and observed that fatigue 
can occur in the absence of acidosis. Another study from 
Westerblad’s laboratory (Bruton et al. 1998) reported that 
mouse muscle fibers did not fatigue more rapidly when they 
had been pre-acidified by 0.4 pH units. However, the major 
challenge to the notion of lactic acid as a fatigue agent has 
come from studies of isolated rat soleus muscles (Nielsen 
et al. 2001; De Paoli et al. 2007) and mechanically skinned 
rat extensor digitorum longus (EDL) muscle fibers (Pedersen 
et al. 2004); [see (Lamb and Stephenson 2006) for additional 
references]. These studies propose that increased [La−] actu- 
ally counteracts fatigue. These investigations first note that 
in one type of fatigue K+ builds up in the transverse-tubular 
(t) system and in the microenvironment of stimulated mus- 
cle fibers. This increase in [K+] leads to sarcolemmal depo- 
larization which may slow or even prevent the recovery of 
Na+ channels from inactivation. This scenario would lead 
to a reduced amplitude of action potentials or maybe fail- 
ure, thereby reducing muscle force production (Lamb and 
Stephenson 2006). In 2001, Nielsen et al. (2001) observed 
that incubation of isolated rat soleus muscles in 11 mM K+
reduced tetanic force by 75%, but this deficit was completely 
eliminated upon addition of 20 mM lactic acid. In 2004, 
Pedersen et al. (2004) performed a sophisticated study of 
mechanically skinned rat EDL muscle fi        fi that 
in the presence of Cl−, acidosis decreased Cl− permeability 
thus preserving the propagation of action potentials into the 
t-tubules despite Na+ channel inactivation. Subsequently, de 
Paoli et al. (De Paoli et al. 2007) reported that a combina- 
tion of 20 mM lactic acid and epinephrine off t an 85% 
reduction in force production by rat soleus muscles in the 
presence of an external 15 mM [K+]. The overall conclu- 
sion of these researchers and others is that lactic acidosis 
is actually beneficial in delaying the onset of fatigue (Lamb 
and Stephenson 2006). 
What is the bottom line? During exercise intensities up 
to maximal lactate steady state (approximately 4 mM blood 
[La−]), La− likely provides an advantage, since it offers a 
means of distributing substrate and perhaps coordinating 
redox state among tissues (see discussion in a later sec- 
tion) with little change in pH (Gladden and Hogan 2006). 
The ability to produce and accumulate La− is also critical 
to maximal effort performance particularly during periods 
of approximately 30–90 s (Gladden 2004a; Brooks 2012). 
In this context, La− plus NAD+ formation from pyruvate 
and NADH via the LDH reaction regenerates the required 
substrate (NAD+) for the glyceraldehyde dehydrogenase 
reaction, permitting continued rapid glycolysis with the 
production of 1.5 ATP per glucosyl unit derived from gly- 
cogen. However, what about the fatigue effects of La− and 
its concomitant acidosis? In our view, many studies of iso- 
lated muscles and fi although not all, disagree not on 
whether lactic acidosis is a negative factor for muscle func- 
tion but on the primacy of acidosis as a cause of fatigue 
during high intensity contractions. In other words, lactic 
acidosis is likely not the primary cause of fatigue, but it is 
nevertheless an important factor. For example, even as he 
argues against the role of acidosis in skeletal muscle fatigue, 
Westerblad (2016) notes decreases of about 10% in maxi- 
mum isometric force in skinned fiber studies due to acidosis. 
As Cairns and Lindinger (Cairns and Lindinger 2008) have 
noted, high intensity fatigue is likely due to multiple ionic 
interactions. Perhaps, a rundown of the transsarcolemmal K+
gradient is the major factor (Cairns and Lindinger 2008), but 
H+ and even La− likely have negative effects, particularly in 
combination with other metabolites such as Pi (Debold et al. 
2016; Fitts 2016). In addition, while there are views to the 
contrary, there is evidence that acidosis inhibits glycolysis 
(Parolin et al. 1999). At the whole-body level, it is possi- 
ble that low tissue pH causes pain and that blood acidosis 
encourages arterial hemoglobin desaturation that can dimin- 
ish aerobic performance (Gladden and Hogan 2006). Finally, 
alkalosis via sodium bicarbonate supplementation generally 
improves high intensity performance by 2–3% (Siegler et al. 
2016). In toto, our conclusion is that both La− and H+ likely 
have some negative eff on exercise performance, albeit 
they are not necessarily the major causes of fatigue. 
Cell‑to‑cell lactate shuttle 
With evidence mounting that hypoxia was not the primary 
cause of La− production, and that La− could in fact be used 
as a fuel by numerous tissues including both resting and 
contracting skeletal muscle, a paradigm shift occurred in 
the conceptualization of La− metabolism during exercise. 
This paradigm shift was impelled (Brooks 1985b) and 
expounded by Brooks (2007, 2009, 2016), beginning in 
1985 (Brooks 1985b) when he introduced the lactate shut- 
tle, now known as the intercellular or cell-to-cell lactate 
shuttle. Key support for the cell-to-cell lactate shuttle came 
from a plethora of isotopic tracer studies by the Brooks 
laboratory which tracked the fl w of carbon intermediates 
during rest, exercise, and recovery in combination with 
arteriovenous measures of net La− exchange, and muscle 
biopsies (Bergman et al. 1999, 2000; Brooks 2002). In 
contrast to the dogma of the 19th and most of the twentieth 
century, which viewed La− as a dead-end, fatigue-causing 
waste product, the now well-supported tenet of the cell-to- 
cell lactate shuttle emphasizes La− as an energy intermedi- 
ate that can be formed in tissues undergoing accelerated 
glycolysis and subsequently distributed throughout the 
body to be taken up as an energy substrate by oxidizing tis- 
sues or as a precursor for gluconeogenesis or glycogenesis. 
The whole of the evidence gleaned from studies of exercise 
metabolism is overwhelmingly supportive of this theory, 
and it is now the framework within which La− metabolism 
is studied. Both the evidence and the concept have been 
extensively reviewed previously (Gladden 1996, 2004a, b, 
2008b; Brooks 2000, 2002, 2007, 2009, 2016; Brooks and 
Gladden 2003), and will, therefore, be only summarized 
here. As extolled by Brooks (2007) and emphasized here, 
this theory is based on La− exchanges: (a) between low- 
oxidative and high-oxidative skeletal muscle fi   allow- ing 
La− to be oxidized within individual working muscles; 
(b) among contracting skeletal muscles producing La− and 
other distant skeletal muscles that are at a lower metabolic 
rate (rest or submaximal exercise); (c) between contracting 
skeletal muscles and the heart; and (d) between tissues 
of net La− release and gluconeogenesis or glyconeogen- 
esis. Essentially, La− is exchanged by tissues throughout 
the body, importantly including the brain (see below) as 
illustrated in Fig. 9. 
Approximately 30 years after the work of Stainsby, 
Welch, and Jöbsis (Stainsby and Welch 1966; Welch and 
Stainsby 1967; Jöbsis and Stainsby 1968), Pagliassotti and 
Donovan (1990) and Gladden et al. (Gladden and Yates 
1983; Gladden 1991; Gladden et al. 1992, 1994; Hamann 
et al. 2001; Kelley et al. 2002) provided clear evidence 
of net La− uptake and metabolism by isolated, perfused 
skeletal muscle under both resting and contracting condi- 
tions. Among many studies in humans also showing net 
La− release by some muscles with net La− uptake by other 
muscles, those of Richter et al. (1988) and van Hall et al. 
(2003) are illustrative. In contracting muscle displaying a 
net uptake of La−, the vast majority of the La− is oxidized 
as a fuel (Mazzeo et al. 1986; Stanley et al. 1986; Bergman 
et al. 2000; Kelley et al. 2002). 
La−  clamp studies in humans further illustrated the 
importance of La− as both a fuel and a gluconeogenic sub- 
strate. Using a combination of [3-13C]lactate, H13CO3− and 
[6,6-2H2]glucose tracers, Miller et al. (2002a, b) main- 
tained arterialized venous plasma [La−] at approximately 
4 mM in subjects exercising at a moderate exercise inten- 
sity (~ 55% V̇ O2peak). Overall, they (Miller et al. 2002a) 
found a signifi  increase in La− oxidation accompa- nied 
by a decrease in glucose oxidation, suggesting that La−
competes successfully with glucose as a carbohydrate fuel 
source. In addition, the La− clamp data of Miller et al. 
(2002b) and Roef et al. (2003) taken together demon- 
strated that La− was an important gluconeogenic precur- 
sor at both low and moderate exercise intensities. These 
La− clamp studies, along with many other investigations 
of diff ent types, emphasize the role of La− as arguably 
the most important substrate for gluconeogenesis, and of 
course, the key role of the liver [e.g., (Connor and Woods 
1982; Nielsen et al. 2002)] as an important player in the 
cell-to-cell lactate shuttle. 
Studies of cardiac muscle, a highly oxidative tissue, 
show that under conditions of elevated blood [La−], ele- 
vated myocardial blood flow, and elevated myocardial met- 
abolic rate; La− can become the preferred fuel, accounting 
for as much as 60% of the myocardial substrate (Gertz 
et al. 1988; Stanley 1991). Essentially, all of this La− taken 
up by the heart is oxidized as a fuel (Stanley 1991). The 
paramount importance of La− as a fuel source for the heart 
is further seen when the heart is stressed via β-adrenergic 
stimulation (Lopaschuk et al. 2010), increased afterload 
(Wyatt et al. 1977), chronotropic challenge (Camici et al. 
1989; Bagger et al. 2000), and shock (Kline et al. 2000). 
Fig. 9 Cell-to-cell lactate shuttle, and the astrocyte–neuron lactate 
shuttle. Based on (Pellerin et al. 1998, Brooks 2002). As the rate of 
demand for ATP increases in exercising skeletal muscle, La− accu- 
mulates and efflux from muscle fibers increases by means of MCTs 
(lower left). Within the exercising muscle, La− is shuttled among het- 
erogeneous fiber types, from glycolytic to oxidative fibers via MCTs 
(small blue squares in lower right). Alternatively, La− may be carried 
in circulation to less, or slightly active skeletal muscle, where it is 
oxidized (CO2 + H2O) in oxidative fibers. In inactive glycolytic skel- 
etal muscle fibers, La− is converted chiefly to glycogen, with some 
oxidized in oxidative fibers. La− is also carried in the blood to the 
liver, where it is either oxidized, or converted to glucose via gluco- 
neogenesis. The newly formed glucose is either stored as glycogen, or 
released back into circulation (Cori cycle), where it can return to, for 
example, exercising muscle. Circulating La− is also readily oxidized 
in cardiac fibers and brain. Within the brain, the astrocyte–neuron 
lactate shuttle (upper right panel) is the process by which astrocytes 
take up glucose from the microcirculation, converting the glucose to 
La− via glycolysis. This astrocytic La− diffuses from the astrocyte to 
an adjacent neuron by means of MCTs. In the neuron, the La− is oxi- 
dized at the mitochondria (CO2 + H2O) to resynthesize ATP, and/or 
used for the cataplerotic production of amino acid neurotransmitters 
(NTs; e.g., glutamate, aspartate, and GABA) 
The brain: part of the cell‑to‑cell lactate shuttle 
and site of the astrocyte–neuron lactate shuttle 
While myocardial tissue has long been appreciated as a 
metabolic omnivore, capable of readily utilizing a variety 
of substrates, the long-standing model for brain metabolism 
identifies glucose as the predominant energy substrate in the 
adult brain (Sokoloff 1989). However, the newborn mam- 
malian brain has been shown to utilize elevated blood La− as 
a substrate, and additionally, consume circulating ketones 
during breastfeeding to meet a substantial portion of energy 
requirements (Pellerin 2010). Subsequent investigations 
with 13C nuclear magnetic resonance spectroscopy explored 
La− metabolism in the resting brain, finding that with base- 
line physiological blood [La−]s, approximately 10% of brain 
energy needs are met via oxidation of La−, with the ability 
to oxidize more as circulating La− levels rise (Boumezbeur 
et al. 2010). 
In hindsight, the ability for neuronal tissue to function on 
alternate substrates seems intuitive for organismal success. 
As first suggested by the laboratory of Holmes and Holmes 
in the 1920s (Holmes and Holmes 1925a, b, 1926, 1927; 
Holmes 1930), later including Ashford and Holmes (1929), 
and recently reviewed by Schurr (2017), it is also now clear 
that in addition to glucose, the brain takes up La−. However, 
a full appreciation of La− as a viable substrate for the brain 
has only recently been realized. In this context, the recycling 
of La− in exercising skeletal muscle served as an important 
model for exploration within the brain. Global brain uptake 
of La− during exercise was reported as early as at least 1972 
(Ahlborg and Wahren 1972). Almost 30 years later, Ide et al. 
observed an increase in La− uptake by the brain during both 
exercise (Ide et al. 1999) and recovery from exercise (Ide 
et al. 2000). It is now well established that with intense exer- 
cise, the brain is activated and this, in conjunction with the 
accompanying elevated arterial blood [La−], leads to a large 
increase in net La− uptake which in fact becomes greater 
than glucose uptake (Ide and Secher 2000; Quistorff et al. 
2008). At the conclusion of exercise to exhaustion, blood 
[La−] was shown to be increased, while concentrations 
within the cerebral spinal fl     and brain were equivalent 
to baseline levels, ruling out La− accumulation and indicat- 
ing La− utilization as a substrate (Dalsgaard et al. 2004). 
In euglycemic adult males, infusion of sodium La− to lev- 
els mimicking mild exercise elicited net La− uptake, with 
a concomitant reduction in glucose uptake of 17% versus 
control (Smith et al. 2003). Clearly, global brain La− metab- 
olism is a part of the cell-to-cell lactate shuttle. There is 
also evidence that regular physical activity slows age-related 
memory impairment (Tsai et al. 2016) and brain tissue loss 
with aging (Colcombe et al. 2003) leading to the notion that 
La− may serve as a link between exercise and improvement 
of cognitive functions (Proia et al. 2016). Recently, Hashi- 
moto et al. (2017) observed a significant correlation between 
executive function and La− extraction by the brain following 
high intensity interval exercise. On the basis of their find- 
ings, they (Hashimoto et al. 2017) proposed that exercise 
training should be above the LT to foster brain activity. 
Broadly, two conceptual hurdles hindered the considera- 
tion of La− as a fuel for the brain. First, a limited apprecia- 
tion that aerobic glycolysis, specifi y cerebral glycoly- sis, 
terminates in La− formation, and second, that La− is an 
important substrate for the brain. In consideration of the first 
point, work from investigators in both skeletal and cardiac 
tissue provided a framework by defining the cell-to-cell lac- 
tate shuttle hypothesis, stating that La− is shuttled from its 
place of formation to distant sites for mitochondrial oxida- 
tion (Brooks 1985b, 1998; Brooks et al. 1999b; Van Hall 
2000; Chatham et al. 2001; Gladden 2004b). Further con- 
tributions from the field of muscle metabolism affirmed that 
La− is always the end-product of glycolysis (Gladden 2004b; 
Rogatzki et al. 2015), and as elegantly summarized by 
Schurr, is the most feasible path when considered thermody- 
namically, chemically, and spatially (Schurr 2006). A second 
hurdle to overcome was development of an experimentally 
supported framework to explain how La− could be utilized 
in the brain. Following the footsteps of the cell-to-cell lac- 
tate shuttle framed by Brooks (see discussion above), this 
conceptual framework has emerged as the Astrocyte–Neuron 
Lactate Shuttle (ANLS) hypothesis (Fig. 9), and in recent 
decades a body of evidence has grown to support La− as an 
oxidizable substrate that is not only taken up from the blood 
but one that is also shuttled within the brain. This is a major 
arena of scientific discovery for which studies of metabolism 
during exercise paved the way. 
Following the introduction of La− shuttling by the Brooks 
group, early evidence suggested that La− could support both 
normal synaptic function, and reactivate glucose-depleted 
synaptic quiescence in hippocampal slices (Schurr et al. 
1988). This was furthered to conclude that La−, rather than 
glucose (Schurr et al. 1997b), is shuttled to post-hypoxic 
neurons to recover function (Schurr et al. 1997c) and that 
the La− is produced in glial cells (Schurr et al. 1997a). At 
approximately the same time that the supportive role of 
La− was being elucidated in the brain, the ANLS framework 
for the contemporary view of neuroenergetics was posited 
(Magistretti and Pellerin 1996). This hypothesis suggests 
that in support of increased neuronal activity, astrocytes 
increase their rate of glucose uptake, glycolysis, and the sub- 
sequent release of La− into the extracellular space, where it 
is then taken up by neurons for oxidation. 
The conceptual evolution of La− shuttling in brain cells 
has grown in complexity over the last two decades. Con- 
ventional metabolic theory suggests that the action poten- 
tials of neurons result in an influx of Na+ ions and an efflux 
of K+ ions activating Na+-K+-ATPase pumps. This con- 
sumes ATP while producing ADP, inorganic phosphate, 
and AMP, each of which further stimulate glycolysis, the 
TCA cycle, and oxidative phosphorylation. In contrast, the 
ANLS hypothesis describes a supportive metabolic milieu 
in which stimulated neurons release glutamate as an excita- 
tory neurotransmitter (Pellerin and Magistretti 1994, 2003; 
Pellerin 2003; Bélanger et al. 2011). Increased activity at 
glutaminergic synapses leads to glutamate uptake by astro- 
cytes through a co-transporter mechanism that carries one 
glutamate, three Na+, and one H+ inward, while a single K+
is exported out of the cell (Attwell 2000; Tsacopoulos 2002). 
In the new model, it is this transport activity which triggers 
the Na+–K+-ATPase activity to restore ionic balance, thus 
consuming ATP and triggering astrocyte metabolism. In the 
intracellular space, glutamate is converted to glutamine in 
an ATP-dependent reaction that is catalyzed by an astrocyte- 
specific glutamine synthetase (Mason 2017). Glutamine is 
released back to the extracellular space, where it is taken 
up by neurons and reconverted to glutamate by glutami- 
nase (Bélanger et al. 2011). This process replenishes the 
pool of excitatory neurotransmitter, while the energy cost 
of the ATPase pumps and glutamine synthesis generate the 
classic stimuli for glycolysis and subsequent La− produc- 
tion: decreased [ATP], increased [ADP], increased [Pi], and 
increased [AMP]. 
Within the ANLS hypothesis, there is a division of labor, 
whereby the astrocyte may be viewed as a supportive cell 
type responsible for the glycolytic production of La−, which 
is subsequently processed oxidatively by the neurons when 
energy demands are increased. Several tenets of the ANLS 
hypothesis are corroborated by the identification of key play- 
ers in the shuttling mechanism. First, neuronal glutamate 
release is facilitated by the excitatory amino acid transport- 
ers (EAATs) with EAAT3 expressed exclusively in neu- 
rons and glutamate uptake via the glia-specific EAAT1 and 
EAAT2 transporters (Bélanger et al. 2011; Mason 2017). 
This neuro-stimulatory traffi king of glutamate provides 
the impetus for increased metabolism and the shuttling of 
La− within the brain. 
Lactate dehydrogenase (LDH), the enzyme responsible 
for the interconversion of pyruvate and La−, is expressed 
in fi e isozymes ranging from oxidative (LDH-1) to gly- 
colytic (LDH-5). The LDH-5 subunit possesses a higher 
maximal velocity (Vmax) and is more commonly expressed 
in glycolytic tissues, often termed “muscle type”. LDH-1 is 
inhibited by pyruvate; thus, increased La− in the presence 
of the LDH-1 isozyme is posited to favor return to pyru- 
vate and ultimately oxidation; this isozyme is often termed 
“heart type”. LDH isozyme distribution correlates with sub- 
strate utilization with the LDH-5 isozyme predominating 
in astrocytes, while LDH-1 is more prevalent in neurons 
(Bittar et al. 1996) [note that a causative role for LDH iso- 
forms remains a matter of debate (Rogatzki et al. 2015)]. 
Additional support is observed in the distribution of the 
monocarboxylate transporters (MCTs) in the brain. MCTs 
allow for monocarboxylate movement across cell barriers 
down their concentration gradients (see discussion below). 
MCT2 transporters are localized to neurons and associated 
with net La− uptake, while the MCT4 subtype is expressed 
in astrocytes and associated with net La− release. High-res- 
olution immunocytochemical methods from rodent studies 
explored MCT distribution in distinctly oxidative versus 
glycolytic compartments and corroborated this MCT dis- 
tribution lending support to the shuttling of glycolytically 
produced La− from the astrocyte to the oxidative neuron 
(Bergersen 2007). However, to repeat a caveat from above, 
these locational–metabolic relationships are correlative and 
not necessarily causal. 
A great deal of experimental support has been generated 
for the ANLS hypothesis of brain metabolism; however, it 
has not been unanimously accepted (Chih et al. 2001; Chih 
and Roberts 2003). A detailed summary was provided by 
Pellerin and Magistretti (Pellerin and Magistretti 2011) with 
review of both supportive, and critical, investigations con- 
cerning the ANLS hypothesis concluding that the ANLS 
model is a useful framework for further investigation to 
better understand the coupling of neuronal activity and 
energetics. 
Lactate and volume transmission 
In the CNS, focused synaptic action via “wired” transmis- 
sion of electrical–chemical signals is a well described means 
by which cells communicate quickly. Another widespread 
form of inter-CNS communication involves activation of 
neurotransmitter systems over relatively large volumes and 
distances of the brain (Agnati et al. 1995; Zoli and Agnati 
1996). Dubbed “volume transmission” by Agnati and Fuxe 
in 1986 (Fuxe et al. 2010), this mode of communication 
relies on diffusion and convection of chemical modulators 
through the brain’s extracellular fl and cerebrospinal 
fluid. As such, volume transmission is conceptually similar 
to paracrine/autocrine signaling, and tends to elicit changes 
more slowly than wired transmission. 
The list of potential agents of volume transmission is 
long, and includes monamines (Fuxe et al. 2010), glutamate 
(Okubo and Iino 2011), and l-DOPA (Gjedde et al. 1993; 
Ugrumov 2009). Evidence also suggests that La− may act as 
a volume transmitter (Lauritzen et al. 2013; Tang et al. 2014; 
Morland et al. 2015). Bergersen & Gjedde (Bergersen and 
Gjedde 2012) forwarded the idea that by acting as a volume 
transmitter through either the GPR81 receptor (and subse- 
quently altering intracellular cAMP levels), or by adjust- 
ing intracellular NAD+/NADH redox ratios (see section on 
whole-body cytosolic redox coupling via La−), La− could 
link the maintenance of brain energy status with cerebral 
blood flow. In this way, La− would be viewed as a mediator 
of metabolic information rather than, or perhaps in addition 
to, a metabolic substrate. 
Lactate transport across membranes 
We now understand La− as a ubiquitous metabolic interme- 
diate operating as both the terminal product of glycolytic 
metabolism and the intermediary to complete oxidation of 
glucose by oxidative phosphorylation. In this framework, 
it is important to understand how La− is rapidly mobilized 
from sites of production and taken up as a source of oxidiz- 
able or gluconeogenic/glyconeogenic substrate in remote 
tissues. For much of the last century, it was thought that 
La− traveled in and out of muscle via simple diffusion [see 
(Gladden 1989) for review]. However: (1) large differences 
in [La−] between blood and muscle during exercise and infu- 
sion; (2) saturation of transmembrane flux in response to an 
increasing [La−] gradient; and (3) inhibition of La− transport 
by chemical agents [see (Gladden 1989) for review] stimu- 
lated the search for a transporter. In the 1970s, the Halestrap 
laboratory reported that cyanohydroxycinnamate (CHC) 
specifically inhibited the proton-linked transport of La− and 
pyruvate into human red blood cells (Halestrap and Denton 
1974; Halestrap 1976). Over succeeding years, kinetics of 
the transporter as well as substrate and inhibitor specificities 
were characterized in detail by both the Deuticke (Deuticke 
1982) and Halestrap (Poole and Halestrap 1993) groups. In 
1990, Roth and Brooks (Roth and Brooks 1990a, b) were the 
first to study La− flux into sarcolemmal vesicles in skeletal 
muscle. They demonstrated that sarcolemmal La− transport 
was concentration dependent, saturable, stereospecific, com- 
petitively inhibited by other monocarboxylates, blocked by 
known inhibitors of monocarboxylate transport, sensitive to 
temperature, and stimulated by [H+] gradients. Their studies 
were at the forefront of an exponential increase of research 
on membrane transport of La−. 
Abundant research has now revealed that transmembrane 
La− movement is broadly accomplished by the Solute Car- 
rier Family 16 (SLC16) proteins, one of 52 SLC families 
(Jones and Morris 2016) with over 300 members (Merezhin- 
skaya and Fishbein 2009). Specifically, MCTs are a family of 
transporters including 14 related proteins, only the first four 
of which are particularly important in the transport of La−, 
pyruvate, and ketone bodies (Halestrap and Wilson 2012; 
Halestrap 2013). The rapidity of La− exchange is dramati- 
cally enhanced by the activity of the MCTs. MCTs 1–4 are 
energy independent (i.e., passive) and facilitate metabolite 
fl down concentration gradients in conjunction with H+
ions (Halestrap and Wilson 2012). Concurrent advances in 
our understanding of the MCT family enabled the conceptual 
shift in our grasp of La− as an intermediate in metabolism. 
Much of what is known concerning the transport of pyruvate 
and La− into and out of cells came from investigations with 
red blood cells (RBCs) (Skelton et al. 1995, 1998), particu- 
larly the work of the Halestrap lab (Halestrap 1976, 2012; 
Poole and Halestrap 1992, 1993; Juel and Halestrap 1999; 
Halestrap and Meredith 2004; Ullah et al. 2006; Halestrap 
and Wilson 2012). 
MCTs 1–4 are responsible for the proton linked exchange 
of MCTs across plasma membranes down their concentra- 
tion gradients. Monocarboxylates; L–La−, pyruvate, d-β- 
hydroxybutyrate, and acetoacetate are driven to enter or 
exit cells based on their concentration gradients as well as 
the H+ ion distribution (i.e., from low pH toward high pH) 
(Halestrap and Wilson 2012). It is important to note that the 
MCT isoforms are not independently responsible for influx 
or efflux, but rather, facilitate concentration-driven transport 
with regulation guided by expression, tissue distribution, and 
cellular location. MCT1 has the broadest tissue distribution 
(Merezhinskaya and Fishbein 2009) and is often, but not 
always, most highly expressed in cellular locations where net 
La− uptake occurs such as heart and oxidative skeletal mus- 
cle. As noted by Halestrap and Wilson (2012), the major dif- 
ferences among MCTs 1–4 are their substrate and inhibitor 
affinities, the tissues in which they are expressed, and where 
they are located within cells. The predominant isomer of 
La− found in humans is L–La− for which MCT1 is stere- 
oselective with Km approximating 3–5 mM for L–La− and 
tenfold higher for d-lactate (Poole and Halestrap 1993). In 
comparison with MCT1, MCT2 has a higher affi for both 
pyruvate (Km = 0.1 mM) and L–La− (Km = 0.74 mM) (Bröer 
et al. 1998). MCT3 has similar kinetic properties to MCT1; 
however, it is restricted to the basal membrane of retinal 
pigment epithelium and choroid plexus epithelium 
(Bergersen et al. 1999; Philp et al. 2001). MCT4 is also 
widely expressed in tissues and has higher expression in tis- 
sues associated with net export of La− such as fast glycolytic 
skeletal muscle, astrocytes, white blood cells, and chondro- 
cytes (Juel and Halestrap 1999; Bonen 2001; Halestrap and 
Meredith 2004). The functional diff ence of MCT4 from 
MCT1 can be appreciated by the Km values for pyruvate 
and L–La− of about 150 and 28 mM, respectively (Bröer 
et al. 1998; Halestrap and Wilson 2012), which presumably 
aids in cellular retention of pyruvate and limits loss of La− to 
higher physiological concentrations. 
In general, MCT1 expression is highly correlated with 
indices of oxidative metabolism in skeletal muscle, while 
MCT4 expression is correlated with indices of glyco- 
lytic metabolism (Juel and Halestrap 1999; Brooks 2000; 
Halestrap and Wilson 2012). It is also generally true that 
chronic changes in muscle activity cause corresponding 
changes in La− transport. Endurance exercise training and 
chronic electrical activity increase La− transport capability, 
whereas inactivity, due to denervation or hindlimb suspen- 
sion as examples, causes a decrease in La− transport capa- 
bility [see (Juel and Halestrap 1999; Bonen 2001; Gladden 
2004a; Halestrap and Wilson 2012) for review]. The main 
change in MCT isoform profile with exercise training or a 
high energy demand stimulus is an increase in MCT1 with 
MCT4 changes being much less (Gladden 2004a; Halestrap 
and Wilson 2012; Thomas et al. 2012). However, in some 
research, hypoxia appears to be a stimulus for increased 
MCT4 mRNA and protein expression in a variety of cells, an 
effect that is likely regulated by HIF-1α (Ullah et al. 2006; 
Halestrap and Wilson 2012). The response of MCTs to an 
acute exercise bout is less clear with some studies report- 
ing an increase in MCT content (Green et al. 2002, 2008; 
Coles et al. 2004; Bickham et al. 2006), while others have 
reported either no change or a decrease in MCT content 
(Tonouchi et al. 2002; Bishop et al. 2007). Overall, Thomas 
et al. (2012) propose that there is a rapid decrease in mem- 
brane MCT1 and MCT4 content between 45 s and 10 min 
after exercise onset, no change from 30 to 80 min and an 
increase in MCT1 content 2 h after exercise onset. However, 
they (Thomas et al. 2012) correctly note that these MCT 
responses to acute exercise are based on only a small num- 
ber of studies, thus further research is needed. There is also 
some evidence that MCT content and maximal La− transport 
capability are not always in perfect concordance, and may be 
independently regulated (Thomas et al. 2012). As one con- 
siders the distribution of MCT isoforms and changes in their 
density and distribution with various stimuli, two caveats 
should always be considered: (1) the MCTs are not inde- 
pendent causative factors in La− transport, because they are 
passive facilitators, regardless of isoform and (2) cells with 
a preponderance of MCT1 such as oxidative skeletal muscle 
fi   tend to have a much greater maximal La− transport rate 
than do cells with a preponderance of MCT4 such as 
glycolytic skeletal muscle fi (Juel et al. 1991; Bonen 
2001; Juel 2001; Gladden 2004a). In this context, it is note- 
worthy that while MCT4 is associated with La− effl its 
kinetic properties are such that it will likely be limiting to 
transmembrane transfer, leading to a [La−] gradient from 
one side to the other (e.g., intracellular to extracellular in a 
La−-producing cell). 
Cytosol‑to‑mitochondria lactate shuttle 
The cytosol-to-mitochondria lactate shuttle (Rogatzki et al. 
2015) describes the continuous glycolytic production, and 
mitochondrial oxidation of La− within the cell of its ori- 
gin (Fig. 10) (Stainsby and Brooks 1990; Hashimoto et al. 
2006; Gladden 2008a; Rogatzki et al. 2015). In this model, 
mitochondria oxidize La− at or near the inner mitochondrial 
membrane, possibly by a La− oxidation complex (Hashimoto 
et al. 2006), but not in the mitochondrial matrix. The NADH 
produced by mitochondrial LDH (mLDH) is reoxidized by 
the malate–aspartate shuttle (MAS) (Kane 2014), or pos- 
sibly other electron shuttles (see below). While evidence 
for mitochondrial MCT1 (as per a La− oxidation complex) 
is not unanimously accepted (Halestrap and Wilson 2012), 
pyruvate transport could be similarly accomplished via the 
mitochondrial pyruvate carrier. As mentioned previously, 
because of the high LDH activity in a diversity of tissues, 
as well as the equilibrium constant for LDH greatly favor- 
ing La−, the predominant result of glycolysis is La− (Kane 
2014; Rogatzki et al. 2015; Schurr 2017). However, it should 
be noted that formation of La− is not synonymous with 
La− accumulation and increased [La−]. In a manner analo- 
gous to the subcellular distributions of the cytosolic versus 
mitochondrial creatine kinase of the phosphocreatine shut- 
tle, the mitochondrial reticulum (Glancy et al. 2015) (and 
its resident intermembrane or juxta-inner membrane LDH) 
serves as a sink for La−, maintaining La− flux irrespective of 
accumulation (Kane 2014; Rogatzki et al. 2015). 
Despite the seemingly straightforward concept of cytosol- 
to-mitochondria La− shuttling, the nature of mitochondrial 
La− metabolism remains a subject to which the following 
quotation of Fletcher and Hopkins (1907), cited earlier, 
might equally apply today: “there is hardly any important 
fact concerning the lactic acid formation in muscle which, 
advanced by one observer, has not been contradicted by 
some other.” A comprehensive treatment of this contentious 
issue is beyond the scope of this review (Brandt et al. 1987; 
Brooks et al. 1999b; Rasmussen et al. 2002; Sahlin et al. 
2002; Ponsot et al. 2005; Hashimoto et al. 2006; Atlante 
et al. 2007; Schurr and Payne 2007; Yoshida et al. 2007; 
Lemire et al. 2008; Passarella et al. 2008, 2014; Gallagher 
et al. 2009; Elustondo et al. 2013; Jacobs et al. 2013; Schurr 
2014; Herbst et al. 2017; Paventi et al. 2017). Suffi it to 
say that at present, discord exists about the precise func- 
tional location of mitochondrial LDH, but that the majority 
of the evidence indicates that LDH is not in the mitochon- 
drial matrix (Baba and Sharma 1971; Brandt et al. 1987; 
Rasmussen et al. 2002; Sahlin et al. 2002; Ponsot et al. 2005; 
Hashimoto et al. 2006, 2008; Yoshida et al. 2007; Hashimoto 
and Brooks 2008; Elustondo et al. 2013; Jacobs et al. 2013; 
Herbst et al. 2017), and therefore, evidence does not favor 
an intracellular lactate shuttle as originally conceptualized 
(Brooks et al. 1999a, b). 
However, it is important to recognize that progress around 
mitochondrial La− metabolism has been complicated for two 
main reasons: (1) technical limitations in subcellular/cel- 
lular studies and (2) the potential differences among tissue 
and cell types. Spectrophotometric monitoring of NADH 
change, for example, has been used repeatedly in the study 
of La− metabolism in mitochondria of diverse origin (Val- 
enti et al. 2002; De Bari et al. 2004, 2010; Atlante et al. 
2007; Pizzuto et al. 2012; Passarella et al. 2014; Paventi 
et al. 2017). This approach is problematic, not least, because 
NAD(H) is a cofactor in a myriad of biochemical reactions 
(Ying 2008), but also because the La−/pyruvate redox cou- 
ple is so closely linked to cytosolic, and not mitochondrial 
matrix NAD+/NADH; not to mention that the latter is orders 
of magnitude more reduced relative to the cytosol (William- 
son et al. 1967; Jones and Sies 2015); see Sahlin et al. 2002 
for discussion (Sahlin et al. 2002). Furthermore, the abil- 
ity of intact mitochondria to oxidize exogenous NADH (to 
which the inner mitochondrial membrane is impermeable) 
is a consistent observation, first reported by Lehninger over 
65 years ago (Lehninger 1951). Similarly, spectrophotomet- 
ric monitoring of NADH change has been used to study the 
rotenone-insensitive, aerobic reoxidation of cytosolic NADH 
via cytochrome b5  reductase in cerebellar granular cells 
(Atlante et al. 1999) and liver outer mitochondrial mem- 
branes (Bernardi and Azzone 1981; Abbrescia et al. 2012), 
as well as the rotenone-sensitive, “exo-NADH oxidase sys- 
tem” in isolated cardiac (Rasmussen 1969; Jørgensen et al. 
1985; Rasmussen and Rasmussen 1985; Nohl 1987) and 
skeletal muscle mitochondria (Szczesna-Kaczmarek et al. 
1984; Rasmussen et al. 2001, 2003a, b). Interpreting NADH 
changes in a system in which LDH is not the exclusive 
NADH oxidoreductase is further complicated in the study 
Fig. 10 Cytosol-to-mitochondria lactate shuttle (Rogatzki  et  al. 2015). 
Based on (Stainsby and Brooks 1990; Hashimoto et al. 2006; Gladden 
2008a; Rogatzki et al. 2015) and combined from  (Kane 2014; 
Rogatzki et al. 2015). The prominent activity of the near- equilibrium 
LDH ensures cytosolic La− formation during most con- ditions, with 
rates increasing in parallel with increased glycolytic activity. The 
figure depicts a skeletal muscle, and not all cells nec- essarily exhibit 
all the processes depicted in the upper right. Com- partmentations 
with glycolytic activity include association with the sarcolemmal 
Na+/K+ ATPase, glycolysis-related reactions, and the Ca2+-ATPase of 
the sarcoplasmic reticulum. La− enters the mitochon- drial 
intermembrane space through porins in the outer mitochondrial 
membrane. Here, mLDH oxidizes La− to Pyr−, reducing NAD+ to 
NADH. Pyr− crosses the mitochondrial inner membrane via the MPC 
and/or MCT1, stabilized by CD147. Note: arguments against mito- 
chondrial MCT have been made; see (Halestrap and Wilson 2012). 
The NADH generated by mLDH is reoxidized by the MAS, which 
shuttles reducing power across the inner mitochondrial membrane. 
This is necessary, because the inner mitochondrial membrane is 
impermeable to NAD+ and NADH. In the matrix, Pyr− is oxidized 
by PDH to acetyl coA, which enters the TCA cycle, generating addi- 
tional NADH. Oxidation of NADH at Complex I is a primary entry 
point of electrons into the mitochondrial electron transport system 
(ETS). The electrons are then passed to the mobile electron carrier 
Q, transported through Complex III, and then to Complex IV/COX 
via cytochrome c. The final electron acceptor at Complex IV in this 
schematic is molecular O2. The drops in free energy occurring across 
the ETS at complexes I, III, and IV are sufficient to drive the extru- 
sion of H+ from the matrix into the intermembrane space, generating 
the proton motive force necessary to drive the synthesis of ATP at 
Complex V/ATP synthase. Omitted for clarity: Complex II/succinate 
dehydrogenase of the TCA/ETS, the glycerol 3-phosphate shuttle, the 
NAD(P) transhydrogenase, and stoichiometries of reactants and prod- 
ucts for all reactions. ADP adenosine diphosphate, ATP adenosine 
triphosphate, C cytochrome c, CD147 chaperone protein for MCT1, 
cLDH cytosolic l-lactate dehydrogenase, CO2  carbon dioxide, CoA 
coenzyme A, H+ hydrogen ion, H2O water, I Complex I/NADH oxi- 
doreductase of the mitochondrial electron system, III Complex III of 
the mitochondrial electron transport system, IV/COX complex IV/ 
cytochrome c oxidase, La− l-lactate; MAS malate–aspartate shuttle, 
MCT monocarboxylate transporter, mLDH mitochondrial l-lactate 
dehydrogenase, MPC mitochondrial pyruvate carrier, NAD+ oxidized 
nicotinamide adenine dinucleotide, NADH reduced nicotinamide 
adenine dinucleotide, O2 molecular oxygen, PDH pyruvate dehydro- 
genase complex, Pyr− pyruvate, Q quinone, TCA tricarboxylic acid 
cycle, V Complex V/ATP synthase 
of mitochondrial La− metabolism by the liberal employment 
of the LDH inhibitor oxamate which also inhibits pyruvate 
transport (Martin-Requero et al. 1986) and the aspartate 
aminotransferase of the malate–aspartate shuttle (Rej 1979; 
Thornburg et al. 2008). Among the potentially unintended 
effects of other agents used, mersalyl is an inhibitor of outer 
mitochondrial membrane cytochrome b5 reductase (Bernardi 
and Azzone 1981); digitonin increases exogenous mitochon- 
drial NADH oxidation in rat liver (Bodrova et al. 1998); 
and Triton X-100 increases exogenous mitochondrial NADH 
oxidation in pigeon heart (Rasmussen and Rasmussen 1985). 
Ironically, Szczesna-Kaczmarek et al. (Szczesna-Kaczmarek 
et al. 1984) even suggested a relationship between extrama- 
trix La− oxidation and the external mitochondrial NADH 
oxidation pathway in muscle; such a system would help 
explain stimulation of NAD+-dependent La− oxidation 
with exogenous cytochrome c added after (Elustondo et al. 
2013), but not before (Jacobs et al. 2013) adding La− to 
permeabilized skeletal muscle fibers, as cytochrome c can 
transfer electrons between cytochrome b5 reductase of the 
outer mitochondrial membrane and cytochrome c oxidase 
(Complex IV) of the electron transport system. 
Recently, Patti and associates (Chen et al. 2016) took a 
more direct approach, using high-resolution mass spectrom- 
etry to study mitochondrial metabolism of La− in cultured 
immortalized cells derived from cervical (HeLa) and lung 
cancer (H460), as well as 3T3-L1 fi   oblasts. Their work 
(Chen et al. 2016) supports the contention that La− plays 
a predominantly anaplerotic/cataplerotic role in proliferat- 
ing cells [vis-à-vis the Warburg/reverse-Warburg eff 
(Warburg 1926)] and is consistent with notions of matrix 
LDH and a mitochondrial La− carrier (Taylor 2017). Nev- 
ertheless, even they (Chen et al. 2016) admitted that they 
were unable to resolve exactly where La− oxidation occurs 
in mitochondria. Because much of the previous research 
does not support matrix La− oxidation, reconciling equivo- 
cal studies will require further investigation. As discussed 
in greater detail below, however (see “Lactate and cancer”), 
cancer and other proliferating cells exhibit metabolic phe- 
notypes distinct from normal or differentiated tissue (Lunt 
and Vander Heiden 2011; San-Millán and Brooks 2017), and 
culture conditions do not replicate fully the tumor micro- 
environment in vivo (Goodwin et al. 2014). Nevertheless, 
a consistent, key finding that emerges among these diverse 
studies is the centrality of La− as a metabolic intermediate 
within and between cells. 
Whole‑body cytosolic redox coupling via La−
Recently, the Rabinowitz laboratory (Hui et al. 2017), using 
stable isotope techniques, rediscovered and reemphasized 
the cell-to-cell lactate shuttle. They (Hui et al. 2017) meas- 
ured the turnover flux of 16 different carbon metabolites in 
mice under non-exercise conditions. Their major contribu- 
tion was the observation that the circulatory turnover fl  
of La− exceeds that of all other metabolites, being 10–150% 
greater than the rate of glucose turnover flux, depending on 
whether the mice were fed or post-absorptive. Furthermore, 
these investigators postulate that the rapid translocation of 
La− across cell membranes (see discussion above) and its 
bulk circulation in the blood positions La−  to serve as a 
means of equating cytosolic NAD+/NADH ratios across 
tissues throughout the body. This is an intriguing, albeit 
not novel (Brooks 2009; Halestrap 2013; San-Millán and 
Brooks 2017) concept. The Rabinowitz group (Hui et al. 
2017) further postulates that this redox function of the cell- 
to-cell lactate shuttle would permit the use of carbohydrate- 
derived energy without the necessity of glycolysis in some 
tissues, while other tissues could modulate glycolytic activ- 
ity to support other needs such as cell proliferation, NADPH 
production via the pentose phosphate pathway, activity of 
brain neurons, and systemic glucose homeostasis (Vander 
Heiden et al. 2009). Halestrap (Halestrap 2013) explains 
that this process is possible because of the exclusively cyto- 
solic location of LDH and the fact that the LDH reaction is 
close to equilibrium in most cells. Furthermore, due to these 
relationships, changes in the cytosolic La−/pyruvate ratio 
can cause changes in the NAD+/NADH ratio and vice versa 
(Halestrap 2013). 
We see merit in these proposals but note two additional, 
important factors. First, while La− rapidly exchanges 
throughout the body, it equilibrates across permeable mem- 
branes in accordance with the [H+] (pH) gradient (Roos 
1975; Gladden and Yates 1983; Roth and Brooks 1990a). 
Systemic pH is in turn regulated by a number of other fac- 
tors [e.g., (Gladden 2008a; Stickland et al. 2013)]. Sec- 
ond, while the cell-to-cell lactate shuttle might coordinate 
cytosolic redox balance among tissues, it will not directly 
impact mitochondrial redox. This is because cytosolic and 
mitochondrial matrix redox states are not in equilibrium 
with each other (Sahlin et al. 2002). The major underlying 
reason for the separate NAD+/NADH ratios between these 
two compartments is that there are nonequilibrium steps for 
electron transfer across the inner mitochondrial membrane. 
For the malate–aspartate shuttle, the nonequilibrium step 
is the exchange of glutamate plus a proton from outside 
the inner mitochondrial membrane for aspartate from the 
mitochondrial matrix (Nicholls and Ferguson 2013). For the 
s,n-glycerophosphate shuttle, the nonequilibrium step is at 
the flavoprotein-linked sn-glycerophosphate dehydrogenase 
reaction within the inner mitochondrial membrane (Nicholls 
and Ferguson 2013). With regard to La− exchange across the 
inner mitochondrial membrane, this is not a mechanism for 
redox equilibration because of the absence of LDH in the 
mitochondrial matrix as discussed in the previous section. 
Lactate as a signaling molecule 
The lactate/pyruvate ratio is the predominant cytosolic redox 
couple for NAD+/NADH. It should, therefore, not be sur- 
prising that the marked rises in [La−] during times of cel- 
lular stress constitute a signaling molecule—a “lactormone” 
(Brooks 2009; San-Millán and Brooks 2017). In addition to 
serving as an oxidizable fuel itself, La− also inhibits lipoly- 
sis (Gold et al. 1963), and proportionally down-regulates 
the oxidation and disposal of glucose [(Miller et al. 2002a, 
b); see discussion earlier]. It is thought that La− achieves 
this lactormone-like regulation of metabolism by interacting 
with the G-protein coupled receptor GPR81 (a.k.a., HCA1) 
on fat cells to inhibit lipolysis (Liu et al. 2009). Though by 
comparison, its level of expression is much greater in adi- 
pose (Cai et al. 2008; Ahmed et al. 2010), GPR81 expression 
in brain (Bergersen and Gjedde 2012; Lauritzen et al. 2014), 
skeletal muscle (Ge et al. 2008; Kuei et al. 2011; Rooney and 
Trayhurn 2011), heart and other tissues (Liu et al. 2009), 
nevertheless, suggests important La− signaling functions in 
these tissues which await complete description. 
La−  can also elicit longer term influence over gene 
expression via hypoxia-inducible factor-1 (HIF-1), a tran- 
scription factor regarded as the master regulator of O2 home- 
ostasis (Semenza 2004). When activated by hypoxia, HIF-1 
regulates the expression of several genes coding for proteins 
involved in glycolysis, La− handling, and metabolism. For 
example, HIF-1 activation increases pyruvate dehydrogenase 
kinase 1 (PDK1) content in mouse embryo fibroblasts (Kim 
et al. 2006), which inhibits pyruvate dehydrogenase (PDH), 
and stems flux away from pyruvate oxidation at PDH, instead 
leading to LDH-dependent La− accumulation. HIF-1 also 
increases the content of some cell membrane glucose trans- 
porters (Wood et al. 1998; Chen et al. 2001; Mobasheri et al. 
2005; Sakagami et al. 2014), and 11 enzymes of glycolysis 
(Semenza 2001), including the main rate-controlling enzyme 
phosphofructokinase (PFK). Increased glucose transport 
and glycolytic activity promote the formation and accumu- 
lation of La−. HIF-1 also increases MCT4 content (Ullah 
et al. 2006), the isoform associated with La− effl from 
glycolytic skeletal muscle. Thus, HIF-1 activation leads to 
both the enhanced formation, and eff e effl of La−. 
Interestingly, HIF-1 and La− exhibit reciprocal activation, 
whereby La− can activate HIF-1, and HIF-1 can promote the 
production of La−. It has been proposed that reactive oxygen 
species may mediate the reciprocal activation of HIF-1 and 
La− production (Nalbandian and Takeda 2016). 
Peroxisome proliferator activated receptor gamma coac- 
tivator-1 α (PGC-1 α), a transcription coactivator widely 
regarded as the master regulator of mitochondrial bio- 
genesis, also plays a role in regulating La− metabolism. 
Upon binding to the estrogen-related receptor-α on an ldhb 
promotor, PGC-1 α promotes the transcription of lactate 
dehydrogenase isoform B (LDHB). Recently, Liang et al. 
(2016) demonstrated not only that exercise stimulated 
the expression of skeletal muscle LDHB, but that overex- 
pression of ldhb in mice acts downstream of the PGC-1α/ 
nuclear receptor regulatory circuit to increase markers of 
mitochondrial content. As with HIF-1, it has been theorized 
that La−-associated reactive oxygen species (ROS) medi- 
ates these PGC-1 α-dependent adaptations (Nalbandian and 
Takeda 2016); though unlike the upregulation of PFK with 
La− in hypoxia, La− appears to downregulate PFK under 
normoxic conditions (Leite et al. 2007, 2011). In what 
may be another example of reciprocal activation, La− also 
appears to upregulate expression and content of some of the 
same proteins upregulated by PGC-1 α, including MCT1 
(Hashimoto et al. 2007; Hoshino et al. 2014) and COXIV 
(Hashimoto et al. 2007), as well as PDK4 and UCP3 (Kita- 
oka et al. 2016). 
The lactormone function of La−  adds to the long and 
growing list of ways in which nature has integrated this unas- 
suming molecule into a diversity of physiological processes. 
It should come as little surprise that as the tools of scientific 
inquiry advance, La− will continue to feature prominently 
in areas of both physiology and pathophysiology (e.g., see 
section on the role of La− in cancer). 
Lactate and cell volume regulation 
There is also evidence of a role for La− in fl volume 
regulation during heavy exercise. During moderate-to- 
intense exercise, hypotonic fluid is shifted out of the vascu- 
lar compartment causing the plasma osmolarity to increase 
(Mack 2012). One of the main reasons for this fl shift 
involves net water movement into contracting muscles due 
to increases in intracellular and interstitial osmolarity caused 
by increases in skeletal muscle intracellular and extracellular 
fluid [La−]. For example, in humans exercising at 75% of V̇ 
O2peak to exhaustion, a three-phase pattern of plasma volume 
shifts is observed, the first of which (first 2 min of exercise) 
is thought to be due to increases in capillary pressure and 
osmotic pressures within the contracting muscle (Lindinger 
et al. 1994). The second phase of plasma volume decrease 
is associated with an increase in muscle metabolites such 
as La− due to increased rates of glycolysis (Lindinger et al. 
1994). The increase in extracellular osmolarity results in a 
volume loss in non-contracting cells; this is hypothesized 
to attenuate plasma fluid losses early in exercise (Lindinger 
et al. 2011). Opposing this loss of fl inactive skeletal 
muscle fibers exhibit a regulatory volume increase mediated 
by ion transport using the electroneutral Na-K-2Cl co-trans- 
porter (Lindinger et al. 2011); however, inward transport 
of La− via MCT1 also contributes (Lindinger et al. 2013). 
Whether a similar role for La− as a mediator of cell volume 
regulation exists in cells of the central nervous system has, 
to our knowledge, not been addressed. Conceivably such a 
role could exist because of the ease with which La− perme- 
ates the blood–brain barrier, and the ubiquity of MCTs in 
brain cells. 
In the eye, it has been suggested that MCTs 1 and 3 
facilitate the volume of the subretinal space via transport 
of lactate and its attendant tonicity (Halestrap 2013), and 
evidence also supports direct transport of water with lactate 
(Zeuthen et al. 1996; Hamann et al. 2003; Li et al. 2016). 
Lactate and cancer 
The history of cancer is complicated and riddled with 
descriptions of masses dating back to as early as 1600 BC 
(The History of Cancer 2002). However, it was not until the 
1920s that detailed experiments on tumor metabolism were 
fi t reported. As reviewed by Otto (Otto 2016), Warburg 
and Minami (Warburg and Minami 1923) placed tumors in 
Ringer solution and observed acidifi upon addition 
of glucose. The acidification was indicated by color change 
from organic pH indicators, while La− was measured in the 
solution chemically. Subsequently, Warburg placed slices 
of a rat hepatoma in a modified manometer and calculated 
La− from the increase in CO2 formation during 30 min of 
incubation. Amazingly, the tumor slice produced La− at a 
rate that was 70 times greater than that of normal liver, kid- 
ney, and heart tissue (Otto 2016)! This high La− production 
rate was independent of the presence of O2. In 1925, the 
Cori’s (Cori and Cori 1925) reported that venous blood from 
a chicken wing with an implanted sarcoma had higher [La−] 
and lower [glucose] than venous blood from the contralat- 
eral, non-tumor wing. Warburg (Warburg et al. 1927) next 
used a rat model to show that the artery feeding the tumor 
always had lower [La−] and higher [glucose] than the vein 
draining it, consistent with La− production by a tumor in 
presumably normoxic conditions. In 1972, Efraim Racker 
called this glucose-avid, La−-producing behavior of tumor 
cells in the presence of adequate O2 supply, the “Warburg 
Eff     (Racker 1972). This eff     is now well known in 
the study of cancer, and research on the topic has skyrock- 
eted since approximately 2000. It has also sparked interest 
among researchers and clinicians as a target for treatment 
(Nijsten and van Dam 2009; Goodwin et al. 2015; Martinez- 
Outschoorn et al. 2017). 
Our current understanding of tumor metabolism is exem- 
plifi by a report from Sonveaux et al. (Sonveaux et al. 
2008). These researchers (Sonveaux et al. 2008) determined 
the metabolic characteristics of two tumor lines via measure- 
ment of O2 consumption, glucose utilization, and La− pro- 
duction. One line, SiHa human cervix squamous carcinoma 
cells, consumed O2 rapidly, used glucose more slowly, pro- 
duced La− more slowly, and oxidized La− as readily as glu- 
cose. The second line, WiDr human colorectal adenocarci- 
noma cells behaved conversely to the SiHa cells in that they 
consumed O2 slowly, used glucose more rapidly, produced 
La− more rapidly, and were much less effective at oxidizing 
La−. In addition, the tumor lines differed in terms of MCT 
expression in that the SiHa cells preferentially expressed 
MCT1, whereas the WiDr cells expressed MCT4. Following 
up on these results in vitro, Sonveaux et al. (2008) obtained 
both SiHa and WiDr tumor biopsies from tumors grown in 
mice from the corresponding cancer cells injected intramus- 
cularly in the rear leg. The SiHa tumors were particularly 
interesting. Within the SiHa tumors, two tumor cell sub- 
populations were documented; one group was located in a 
well-vascularized, well-oxygenated area of the tumor and 
the other was located in a poorly vascularized, hypoxic area. 
MCT1 was expressed in the oxygenated cells but not in the 
hypoxic cells. Again, following in the footsteps of exercise 
metabolism research, Sonveaux et al. viewed the whole of 
their results and hypothesized a La− shuttle in which La− is 
produced by the hypoxic tumor sites and oxidized as a fuel 
in the normoxic sites. In a commentary further detailing the 
potential facets of such a shuttle, Greg Semenza, himself 
the discoverer of HIF1-α (Semenza and Wang 1992), stated, 
“Was there any precedent that should have alerted us to the 
existence of this symbiotic relationship between aerobic 
and hypoxic cancer cells? Of course: the well-known recy- 
cling of lactate in exercising muscle” (Semenza 2008). This 
began the incorporation of knowledge gained from study- 
ing La− metabolism in exercise physiology, particularly the 
work of G. A. Brooks, into tumor physiology. 
The Warburg cancer cell profile is characterized by sev- 
eral features. First, there is an increase in glycolytic enzymes, 
sometimes by as much as 500-fold (Moreno-Sánchez et al. 
2007; San-Millán and Brooks 2017). The ample carbohy- 
drate fuel supply that is critical for Warburg cells is aided by 
an increased expression of glucose transporters, particularly 
GLUT1, a phenomenon that is associated with aggressive 
tumors and a poor prognosis [e.g., (Kunkel et al. 2003; San- 
Millán and Brooks 2017)]. Note that the basis for the whole- 
body non-invasive PET scan (18F-fluorodeoxygluscose pos- 
itron emission tomography) technique for diagnosing and 
monitoring cancer progression is based on the high glucose 
uptake by tumor cells (Jadvar et al. 2009). Since La− is the 
terminal end-product, it is not surprising that MCT1 and 
MCT4 transporters are often overexpressed in many types 
of cancers [e.g., (Kennedy and Dewhirst 2010; San-Millán 
and Brooks 2017)], and are in fact, correlated with a poor 
prognosis and high mortality (Pértega-Gomes et al. 2011). 
The underlying causes of these changes and of cancer itself, 
are numerous, complicated, and incompletely understood 
[e.g., (San-Millán and Brooks 2017)]. Intriguingly, Sán- 
Millan and Brooks (2017) have even proposed that the ele- 
vated La− production and subsequent increased [La−] (up to 
40-fold) are central signaling players in the generation of the 
Warburg cell profile. The primary LDH isoform in Warburg 
cells is LDHA (Semenza et al. 1996; Vander Heiden et al. 
2009; Granchi et al. 2010; San-Millán and Brooks 2017) 
which has been argued to promote La−  production [e.g., 
(Everse and Kaplan 1973; Granchi et al. 2010)] and to nega- 
tively impact prognosis [e.g., (Sheng et al. 2012; Shi et al. 
2014; Huang et al. 2016)]. Knockdown of LDHA has been 
an experimental approach to cancer treatment and it has met 
with some success [e.g., (Fantin et al. 2006; Vander Heiden 
2011; Wang et al. 2015)]. However, it is not clear that LDHA 
has been inhibited independently of total LDH activity. We 
have previously expressed our skepticism that LDH isoform 
profile is a determinative factor in net La− production and 
accumulation (Rogatzki et al. 2015). This reprogramming 
of cell metabolism in many, perhaps most cancer cells, is so 
dramatic and widespread that it has been proposed as a new 
hallmark of cancer (Hanahan and Weinberg 2011). 
One might ask why cancer cells would gorge on glucose 
and only partially realize its full energy potential by empha- 
sizing La− production rather than full oxidation. An older 
idea (Potter 1958) that has been re-derived (Vander Heiden 
et al. 2009; Hanahan and Weinberg 2011; Martinez-Out- 
schoorn et al. 2017) is that this metabolic scheme provides 
building blocks for proliferation. Because the organism 
absorbs the burden of regulating blood glucose concentra- 
tion, the tumor cells are awash in fuel, thus negating any 
substrate limitation. Subsequent to the rapid use of glucose, 
glycolytic intermediates are diverted into numerous biosyn- 
thetic pathways. Included in these proliferative pathways are 
the generation of nucleosides and amino acids, providing the 
foundational materials for macromolecules and organelles 
which can ultimately constitute new cells via rapid cell divi- 
sion. Faster conversion of fuel into biomass maximizes the 
rate of growth; proliferation rather than effi may be 
the “goal” of the cancer cell (Vander Heiden et al. 2009). An 
additional benefit of increased La− production and efflux to 
the cancer cell might be the acidification of the extracellular 
milieu, which is believed to facilitate cell invasion of sur- 
rounding tissue and metastasis (Gatenby and Gillies 2004; 
Gillies and Gatenby 2007). 
Given the Warburg cell’s dependence on glucose as a fuel, 
a clever notion is to deprive tumors of glucose and thereby 
either kill them, weaken them, or heighten their susceptibil- 
ity to other treatments (Nijsten and van Dam 2009). It is 
well known that depriving cultured cancer cells of glucose 
is frequently detrimental to growth [e.g., (Aykin-Burns et al. 
2009; Choo et al. 2010; Graham et al. 2012)]. However, how 
can the organism survive the glucose deprivation required to 
damage cancer cells? Nijsten and van Dam (Nijsten and van 
Dam 2009) proposed making patients severely hypoglycemic 
while using La− as an alternative fuel; i.e., lactate-protected 
hypoglycemia (LPH) (Goodwin et al. 2015). As revealed in 
the cell-to-cell lactate shuttle, most normal cells (but not 
Warburg cells) can readily use La− as a fuel. A particular 
concern, despite studies showing that the brain can oxidize 
La−, is whether or not the brain can survive in the face of 
severe hypoglycemia (< 1 mM). A case study encouraged 
this idea. Oldenbeuving et al. (Oldenbeuving et al. 2014) 
reported the case of a patient arriving at the emergency 
room with what is usually considered nonsurvivable hypo- 
glycemia (0.7 mM); however, his arterial [La−] was 25 mM. 
The patient, suffering from paracetamol-induced acute liver 
failure, was ambulating and speaking, presumably due to 
the use of La− as a fuel by his vital tissues, particularly the 
brain. Subsequently, Goodwin et al. (Goodwin ML, Rogatzki 
MJ, Sun Y, McDonald JR, Lee K, Oldenbeuving G, Nijsten 
MWN, Gladden LB, unpublished results) attempted LPH in 
an anesthetized canine model. As shown in Fig. 11, Panel A, 
three animals were made severely hypoglycemic via a com- 
bination of insulin, propranolol, and ethanol/phenformin; 
once severe hypoglycemia was reached, the anesthetized 
animals survived on the average about 30 min as indicated 
by isoelectricity on the electroencephalogram. In contrast, 
two animals were made hyperlactatemic ([La−] = ≈ 10 mM; 
Fig. 11B) prior to initiating severe hypoglycemia. Those 
two animals survived at least 5 h before brain isoelectricity 
occurred. These results offer the tantalizing possibility that 
the brain can survive severe hypoglycemia for at least several 
hours in the presence of hyperlactatemia. 
Unfortunately, it is possible, perhaps likely, that the idea 
of treating cancer with LPH is overly simplistic. Work from 
Lisanti’s lab (Pavlides et al. 2009; Gladden et al. 2011; Whi- 
taker-Menezes et al. 2011) found that when MCF7 breast 
cancer cells were co-cultured with normal fi  oblasts, the 
fi oblasts began to express MCT4, something they failed 
to do when cultured alone. Furthermore, the breast cancer 
cells in this co-culture demonstrated an upregulation of 
MCT1. This group (Pavlides et al. 2009; Whitaker-Men- 
ezes et al. 2011; Witkiewicz et al. 2012) has proposed that 
these results are part of a shuttle between stromal fibroblasts 
which display aerobic glycolysis, producing La−, which is 
subsequently taken up by the neighboring cancer cells and 
oxidized as a fuel. The behavior of the cancer cells in this 
scenario was described as ‘Reverse Warburg’ (Pavlides et al. 
2009). Overall, these results are a warning to remember 
that tumors are a heterogeneous collection of normal tissue 
cells, immune cells, blood vessels, and cancer cells, some of 
which may be of a Warburg phenotype, while others are of a 
Reverse-Warburg type (Hanahan and Weinberg 2011; Mar- 
tinez-Outschoorn et al. 2017; Potter et al. 2016; Lytovchenko 
and Kunji 2017). Some areas of the tumor may be hypoxic, 
while others are amply supplied with O2. Still other areas are 
nutrient deficient or nutrient rich, and this landscape is likely 
to change as the tumor infiltrates and proliferates (Hanahan 
and Weinberg 2011; Martinez-Outschoorn et al. 2016; Potter 
et al. 2016; Lytovchenko and Kunji 2017). 
As a result, it should be emphasized here that cell cul- 
ture experiments in vitro can afford excellent control of the 
local environment, but also can be quite misleading, as so 
much of cancer cell behavior depends on a complex and 
poorly understood tumor microenvironment (Goodwin et al. 
2015). In addition, an often-unrecognized shortcoming of 
Fig. 11  Demonstration  of  lactate-protected   hypoglycemia   (LPH) 
in anesthetized dogs. A Experimental manipulation of [glucose] in 
anesthetized dogs (n = 3) as described in the text. Once blood [glu- 
cose] was reduced to < 1 mM, time to brain isoelectricity (death) 
was ~ 0.5 h. In B, the same protocol was repeated (n = 2) but with 
prior and continued infusion of exogenous La− to almost ten times 
normal and clamped there (~ 10 mM). Subsequently, time to isoelec- 
tricity was increased 10-fold (> 5.5 h), substantiating for the first time 
in whole animals what had been suspected from clinical case reports 
(Oldenbeuving et al. 2014) and decades of data demonstrating La−’s 
ability to be transported and utilized as a fuel throughout almost all 
tissues of the body (Gladden 2004b). This proposed LPH (Nijsten 
and van Dam 2009; Goodwin et al. 2015) might function for at least 
a period of hours. Note different scales on x- and y-axes in Pan- 
els A versus B. Data are from unpublished results of Goodwin ML, 
Rogatzki MJ, Sun Y, McDonald JR, Lee K, Oldenbeuving G, Nijsten 
MWN, Gladden LB 
cell studies in vitro is that the cells are typically exposed 
to ambient O2 levels; these levels are extremely hyperoxic 
in comparison with conditions observed in vivo. Accord- 
ingly, studies utilizing whole limbs or animals likely provide 
a more nuanced understanding of how the tumor interacts 
with its microenvironment, including its production and/or 
consumption of La−. Sauer and Dauchy (1985) measured 
arteriovenous diff ences across tumors in their rat model 
and demonstrated that most tumors were net La− produc- 
ers when the arterial [La−] was below 2.5 mM; they subse- 
quently utilized La− as a fuel when arterial [La−] was above 
2.5 mM (Sauer and Dauchy 1985). It is likely that the degree 
to which tumors globally utilize La− as a fuel ultimately 
depends on cell type, available substrate, and specific micro- 
environment. Targeting this remarkably flexible metabolism 
as a means to combat cancer is a formidable challenge! 
While targeting La− metabolism per se may prove to be 
quite difficult, recent work suggests that La− is also a potent 
signaling molecule (see above as well), driving HIF1-α, 
VEGF, and ultimately angiogenesis (Goodwin et al. 2014). 
Lactate’s role as a signaling molecule was fi t described 
as a glycolytic metabolite that could, independent of O2, 
induce angiogenesis (Murray and Wilson 2001); this has 
now expanded with both theoretical and experimental sup- 
port into the cancer literature. A recent review (Goodwin 
et al. 2015) highlights this lactate-to-angiogenesis pathway. 
Briefl , LDH is near-equilibrium and any increase in gly- 
colysis will increase both [La−] and [pyruvate]. Increased 
[pyruvate] inhibits formation of 2-oxoglutarate, the mole- 
cule typically responsible for degradation of HIF1-α. Thus, 
increases in [La−] and [pyruvate] independent of O2 tension, 
can drive stabilization of HIF1-α and lead to angiogenesis. 
This has been demonstrated in several experimental designs 
but is yet to be implemented clinically. Most recently, the 
Kevin B. Jones lab in Utah introduced a novel transgenic 
mouse sarcoma model which resulted in mouse tumors that 
were indistinguishable from the human tumor (Goodwin 
et al. 2014). These tumors formed in areas of high [La−] 
and expressed large amounts of HIF1-α despite normoxic 
conditions. As further confirmation of La−’s potent role as 
a signal, daily exogenous La− administration led to dramatic 
upregulation in the vascularity of these already well-vascu- 
larized tumors. 
Research in skeletal muscle provided the early framework 
from which clinical application has now begun in both the 
central nervous system and tumor research. While many 
active clinical areas are currently under investigation (see 
section “Lactate in clinical applications”), research extend- 
ing what is known about La− metabolism in muscle to now 
include the brain and tumors has raised as many questions as 
it has answered. Given La−’s central role as the metabolite 
by which whole-body metabolism is coordinated (Gladden 
2004b), opportunities for clinical application are numerous. 
Lactate in clinical applications 
Given the confusion surrounding lactate research over the 
last 100 years, it is not surprising that in many ways clini- 
cal application has lagged even further behind. Originally 
thought of as a “hypoxic waste product”, many clinicians 
still view La− in this manner. [La−] is most often used by 
hospitals today in the trauma setting as an indicator of 
“resuscitation.” While frank dysoxia will obligatorily engen- 
der an elevated [La−], an elevated [La−] clearly does not 
typically indicate clinical hypoxia or hypoperfusion, a point 
that continues to cloud clinical interpretation. To compli- 
cate matters, [La−] during the first 48 h in the hospital has 
remained one of the best indicators of clinical outcomes, 
with persistently elevated [La−] being a relatively good pre- 
dictor of surgical complications and even mortality (Clar- 
idge et al. 2000). Although typically reported as “clearance” 
in multiple papers (and even in their titles!) (Odom et al. 
2013), concentration and not clearance is almost exclusively 
what is actually measured in the trauma and critical care set- 
ting (Goodwin and Rothberg 2014). 
Many large clinical trials have examined [La−] and 
clinical outcomes in the trauma and critical care setting. 
However, careful review of the literature calls into ques- 
tion the rationale for La−-guided treatment in clinical 
practice. Pölönen et al. (Pölönen et al. 2000) used goals of 
[La−] < 2.0 mM and SvO2 > 70% in the 8 h postoperative 
window in 403 bypass patients, utilizing additional IV fluids 
and dobutamine in an attempt to reach these goals. While 
the treatment group had less organ dysfunction and shorter 
length of stay by 1 day, only 57% actually met the goals 
(versus 42% in the control group) and [La−] was not differ- 
ent between groups at any sampling time, suggesting that 
under-resuscitation/hypoperfusion is likely not the reason 
for continued La− elevation in this setting (Pölönen et al. 
2000). This type of goal-driven therapy has been repeated 
in septic shock patients, indicating some improvements 
with the additional treatments, but little to no difference in 
[La−] between groups (Rivers et al. 2001; ProCESS 2014). 
Perhaps the most often cited study is from the Netherlands 
(Jansen et al. 2010), in which 348 ICU patients underwent 
goal-directed therapy in a randomized controlled trial with 
a goal of decreasing [La−] by 20% every 2 h for 8 h utiliz- 
ing fluids and vasodilators. The treatment group did receive 
significantly more fluid and medication, with a slight change 
in adjusted in-hospital and ICU (but not 28-day) mortality. 
However, [La−] was not significantly different between the 
two groups at any time. Despite these results, the authors 
conclude that “lactate monitoring during the fi  t 8 h of 
ICU admission, aimed at reducing lactate levels by 20% 
per 2 h, signifi y reduced ICU length of stay and also ICU 
and hospital mortality…” Despite no change in [La−] 
between the groups, this study (Jansen et al. 2010) continues 
to be cited as a reason that La−-guided treatment should be 
utilized. 
The question looming over these trials is why [La−] 
remains elevated despite interventions that increase car- 
diac index and/or perfusion, and thereby global O2 deliv- 
ery. This has led many clinicians to use the phrase “occult 
hypoperfusion,” in reference to the noted elevated [La−] 
in patients in whom no perfusion deficit can be found and 
attempts to increase perfusion do not alter [La−]. Clinicians 
often cite visceral organs as being the site of ischemia, yet 
this has been diffi to demonstrate in normal trauma or 
critical care settings. For example, clamping off the superior 
mesenteric artery in animals, making much of the bowel 
ischemic, fails to induce enough La− production to increase 
arterial [La−] to a significantly different level (Heino et al. 
1997; Tenhunen et al. 2001). Consistent with this, improving 
the microcirculation of critical organs in critically ill patients 
does not alter arterial [La−] (Trzeciak et al. 2008). 
We are intensely skeptical of “occult hypoperfusion” in 
these cases, and propose instead that the increased [La−] 
is due to nonhypoxic mechanisms. Clinically, increases in 
blood [La−] due to hypoxia is likely the exception rather than 
the rule. Dysoxia is difficult to evoke, even during intense 
exercise. Richardson et al. (1995), cited earlier, had subjects 
inspire 12% O2, yet muscle PiO2 remained above the level 
of O2-limited mitochondrial function. Furthermore, even in 
conditions of very high [La−] after exercise or seizures, once 
the stimulus is removed, [La−] rapidly returns to normal lev- 
els within a few hours. In the trauma setting, [La−] may 
remain elevated for several days in patients who ultimately 
have poor clinical outcomes, suggesting some underlying 
metabolic derangement. While it is beyond the scope of 
this review, this persistent [La−] elevation may be due to 
the underlying stress response of trauma or critical care, as 
catecholamines stimulate ß-adrenergic receptors on skeletal 
muscle, liberating skeletal muscle glycogen as La− (Clutter 
et al. 1980; Stainsby et al. 1987). This response has previ- 
ously been described in burn patients (Gore et al. 1991), 
and numerous lines of animal and human studies support 
this hypothesis as the mechanism for elevated La− in many 
trauma and critical care patients (Irving 1968; Daniel et al. 
1976a, b, 1978; Benedict and Grahame-Smith 1978; Liddell 
et al. 1979; James et al. 1996, 1999a, b; Luchette et al. 2002; 
Garcia-Alvarez et al. 2014). 
Given La−’s now well-supported role as both fuel and 
signaling molecule, it is worth noting that its prolonged ele- 
vation with trauma or critical illness may simply represent 
the body in a state of prolonged stress, and the La− elevation 
a result of prolonged catecholamine elevation in an effort to 
mount a “fight or flight” response. Nonetheless, prolonged 
elevated [La−] remains a useful clinical marker across mul- 
tiple disciplines, and it is always prudent to ensure adequate 
oxygenation. Venkatesan et al. (Venkatesan et al. 2015) dem- 
onstrated that hip fracture patients with [La−] > 3.0 mM on 
arrival have four times the 30-day mortality as those with 
[La−] < 3.0 mM on arrival. Claridge et al. (Claridge et al. 
2000) followed [La−] for 24 h after admission to the ICU 
for trauma; those who had [La−] that remained > 2.5 mM at 
12 h had six times the mortality and four times the infection 
rate of those who normalized before 12 h. Multiple examples 
of this are found in the clinical literature, and it remains a 
good predictor of how a patient might do, despite the gross 
mechanistic misinterpretation by many clinicians. Finally, 
studies that simply alter the [La−] do not change the poor 
prognosis of these patients [e.g., with DCA to activate 
PDH complex and drive increased formation of acetyl CoA 
(Stacpoole et al. 1992)], further highlighting the indirect 
nature of the relationship between [La−] and clinical out- 
comes. It is apparent that the mechanisms underlying an 
elevated [La−] must be the problem. 
In opposition to the negative consequences associated 
with elevated [La−] in many critical care and trauma situa- 
tions, there is growing evidence that deliberate induction of 
hyperlactatemia may be beneficial in some conditions. As 
summarized by Ichai et al. (2014), La− infusion has elic- 
ited improved myocardial function in patients with septic 
shock, after cardiac surgery, and with acute heart failure 
(Nalos et al. 2014). Positive results have also been found 
for La− infusion in traumatic brain injury (Ichai et al. 2013, 
2014; Brooks and Martin 2014; Quintard et al. 2016). In 
addition, La− has been proposed as a salvage fuel in the use 
of severe hypoglycemia as a potential therapy in the treat- 
ment of tumors exhibiting the Warburg effect (Nijsten and 
van Dam 2009) as discussed above. 
Yes, Virginia, there is a lactic acidosis 
While lactic acid has long been known as a strong biologi- 
cal acid (pKa= 3.86), hypotheses centering on its formation 
and eff in vivo seem to have clouded the picture. Fol- 
lowing an earlier proposal by Hochachka and Mommsen 
(1983), Robergs et al. (2004, 2005, 2006; Robergs 2008) 
have asserted that there is no lactic acidosis during exer- 
cise (or any other condition perhaps). This assertion is prof- 
fered on the basis of a detailed accounting of the reactions 
of glycolysis, concluding that (1) La− is the biochemical 
end-product of glycolysis, not HLa, (2) the LDH reaction 
from pyruvate to La− “consumes protons” (H+), and (3) the 
acidosis typically seen in conjunction with increasing [La−] 
is due to the hydrolysis of ATP that was not produced by 
oxidative phosphorylation inside mitochondria; i.e., non- 
mitochondrial ATP. However, disregarding the question of 
whether or not La− is the only physicochemical contribu- 
tor to the acidosis of exercise (it likely is not) (Böning and 
Maassen 2008a, b; Lindinger and Heigenhauser 2008a, b; 
Gladden 2008c), there are signifi errors in Robergs’ 
claims. First, the argument that the major source of protons 
is the hydrolysis of non-mitochondrially produced (glyco- 
lytic) ATP hinges on a decreasing concentration of ATP. In 
fact, ATP concentration changes relatively little under most 
conditions. Studies of phosphagen concentration in skeletal 
muscle during exercise date back to those of Hultman and 
colleagues (Hultman et al. 1967; Gollnick and Hermansen 
1973) who showed that while phosphocreatine concentra- 
tion declined linearly with increases in exercise intensity, 
changes in [ATP] were comparatively minor. Second, even 
though it is agreed that La−, not HLa, is produced by glyco- 
lysis (Jones 1980; Robergs et al. 2004), La− cannot exist in 
isolation. La− must immediately be in equilibrium with the 
same pH as all other acids in solution; this is the isohydric 
principle. 
So, whether HLa is viewed as (1) a strong biological 
acid which is almost entirely dissociated at usual muscle 
and blood pH values, or (2) a signifi    contributor to the 
strong ion difference [SID; (Stewart 1981; Kellum and 
Elbers 2009)], both constructs entail an acidifying effect of 
La− accumulation. Aside from basic principles, Marcinek 
et al. (2010) have found that there is close relationship 
between pH decline and La− accumulation with constant 
[ATP] in direct experimental testing. Specifically, they 
(Marcinek et al. 2010) measured pH and [ATP] in ischemic 
mouse muscle using 31P-MRS, and intracellular [La−] chem- 
ically. Even with no change in [ATP], their calculated H+
generation agreed closely with the increase in [La−] over the 
course of the ischemic period. 
Certainly one could argue that if pyruvate instead of 
La− accumulated during exercise or some other glycolytic 
stimulus, then the [H+] would increase more, because pyru- 
vic acid is a stronger acid than HLa. However, it is La− rather 
than pyruvate that increases dramatically because of an equi- 
librium constant for the LDH reaction that is strongly in 
favor of La− (Lambeth and Kushmerick 2002). In fact, the 
La− to pyruvate ratio ranges from about 10:1 at rest to values 
as high as 159:1 in skeletal muscle immediately following 
exhaustive dynamic exercise (Sahlin et al. 1976; Rogatzki 
et al. 2015). In conclusion, increases in [La−] do have an 
acidifying effect. 
Conclusion 
Prebble (2010) has documented that it was research focused 
on muscle metabolism by a group of biochemists that led 
to discovery of the glycolytic pathway while also laying 
the foundation for discovery of the origins of aerobic phos- 
phorylation. Most of these biochemists had the common 
influence of the Otto Meyerhof laboratory (Prebble 2010). 
Of course, the quest for an understanding of La− produc- 
tion and removal in muscle was an important linchpin of 
the glycolytic research. Allchin (2002) asserts, and we 
agree, that understanding cellular metabolism/bioenerget- 
ics is a great achievement of the twentieth century that has 
not been acclaimed to the same extent as advancements 
in evolution, genetics, and molecular biology (Prebble 
2010), but should be. Within this wondrous web of cellular 
bioenergetics, Scheele’s little three carbon molecule seems 
to grow in importance. Should this be surprising? No. For 
most vertebrates, and certainly mammals, there are two 
ATP-generating systems, glycolysis and oxidative phos- 
phorylation. Glycolysis does not require O2 and has La− as 
its end-product, because the equilibrium of the LDH reac- 
tion is markedly in favor of La−. La−, then, is an immediate 
reservoir supplying pyruvate to mitochondria for complete 
oxidative combustion. Therefore, La− stands at the intersec- 
tion of anaerobic and aerobic metabolism of carbohydrate 
fuel. La− may also coordinate cytosolic redox state among 
tissues throughout the body. It is of little wonder, then, that 
we find La− involved throughout intermediary metabolism, 
including both global extraorgan exchange and intra-tissue 
exchange. 
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